Abstract
The aim of this review is to perform a systematic review of scientific papers and an in-depth analysis of the latest research related to Paeonia × suffruticosa Andrews as a valuable plant species, important in pharmacy and cosmetology. P. × suffruticosa bark root-Moutan cortex is a medicinal raw material formerly known from traditional Chinese medicine (TCM) but less common in official European medicine. It was introduced for the first time in the European Pharmacopoeia Supplement 9.4 in 2018. In this work, the numerous possible applications of this raw material were depicted based on modern professional pharmacological studies documenting its very valuable medicinal values, including antioxidant, cytoprotective, anti-cancer, anti-inflammatory, cardioprotective, anti-atherosclerotic, anti-diabetic and hepatoprotective activities. The scientific studies indicated that the profile of raw material activity is mainly due to paeonol, paeoniflorin and 1,2,3,4,6-penta-O-galloyl-β-D-glucopyranose. Moreover, the significance of this plant (its different organs) in the production of cosmetics was underlined. P. × suffruticosa finds increasing application in cosmetology due to research on its chronic dermatitis, anti-aging and brightening effects. Furthermore, some biotechnological research has been described aimed at developing effective in vitro micropropagation protocols for P. × suffruticosa.
Keywords: tree peony, moutan, paeonol, paeoniflorin, therapeutic effects, cosmetic applications
1. Paeonia Genus and Paeonia lactiflora and Paeonia veitchii as Known Medicinal Plants—General Characteristic
The classification of the genus Paeonia (Paeoniaceae) is complex from a taxonomic point of view. The species are divided according to three sections: Moutan DC., Paeon DC. and Onaepia Lindley [1,2]. The section on Moutan DC. contains the evolutionarily older shrub peonies. The Moutan section has two subsections: subsect. Vagintae and subsect. Delavayanae including peony species, such as P. cathayana, P. decomposita, P. jishanensis, P. ostii, P. qiui, P. rockii, P. rotundiloba, P. delavayi, P. ludlowii and P. suffruticosa [1,3]. Paeon DC. is an extensive section consisting of 26 varieties of herbaceous plants with fleshy leaves with deep indentations. Characteristic species here include P. lactiflora and P. veitchii [1]. In the section Onaepia Lindley, there are several species of peonies with grassy leaves, including P. brownii and P. californica [1].
The Latin name of the genus, ‘Paeonia’, is derived from Greek legend about Paeon and Pluto. Paeon was a disciple of Aesculapius, the Greek god of medicine. According to the legend, Paeon used a peony concoction to heal Pluto, who had been wounded in the Trojan War. Aesculapius, jealous of his student’s healing skills, plotted to kill Paeon. Pluto discovered it and thwarted the plot by transforming Paeon into a peony [4].
Peonies are native to Asia, Europe and North America. The section Moutan DC., which contains all woody species, is restricted in the wild to Central and Southern China, including Tibet. The section Onaepia is present in the west of North America, and the section Paeonia occurs in a band stretching roughly from Morocco and Spain to Japan [5].
Today, peonies are very popular plants as ornamental species. More than 1200 varieties of Chinese and tree peonies have already been bred, mainly in China and Japan, but also in other geographical areas, including France, England and the United States. In Europe and North America, peonies are planted in gardens and parks for their showy flowers of great aromatic and ornamental value; the flowers range in form and color from snow-white, light and dark pink, to bright red and burgundy [6].
The known pharmacopoeial raw materials of the genus Paeonia (Peony) are the roots extracted from two species: Paeonia lactiflora Pall. and P. veitchii Lynch. The monographs Paeoniae radix rubra (peony red root) and Paeoniae radix alba (peony white root) are listed in the 10th edition of the European Pharmacopoeia [7]. These raw materials are also listed in the modern Chinese Pharmacopoeia [8] and are accepted by the Committee on Herbal Medicinal Products (HMPC) [9]. Paeoniae radix rubra is extracted from the species Paeonia lactiflora and P. veitchii; it is the whole root dried in the sun with the reddish, thick outer bark and with only the rhizome and rootlets removed. Paeoniae radix alba can only be obtained from P. lactiflora; the bark is removed from the root and the exposed powdery-white layer is the raw material subjected to boiling and then drying [10]. According to the requirements of the European Pharmacopoeia, raw materials are to be standardized for paeoniflorin content. The red root should contain a min. 1.8% of this compound, while white 1.6% [11]. Paeoniae radix rubra is mostly used to treat hematemesis, warm toxin, amenorrhea, dysmenorrhea, blood stasis, abdominal pain, red eyes, headache and carbuncles. Paeonia radix white has a biological effect such as to treat irregular menstruation and to protect the liver [12,13,14].
Both P. lactiflora and P. veitchii are species that have their natural habitats in Asia (mainly in China and Siberia). P. lactiflora Pall. (Milk Quince Peony) is popular in ornamental horticulture. There are 5000 varieties in the world. In Ukraine, cultivars grown as P. lactiflora are perennials and may differ in size and shape, color, color and flowering time. Hybrids and varieties of P. lactiflora are grown in gardens and orchards and are used in folk medicine [15,16,17]. Interestingly, these raw materials in Traditional Chinese Medicine (TCM) have quite different medicinal uses. Red root, according to TCM, is administered for febrile conditions, to reduce swelling and for menstrual disorders [18]. White root is used as an analgesic, sedative and anti-inflammatory agent. It is also found in the composition of herbal mixtures used to treat depressive disorders. However, modern pharmacological research indicates that both raw materials have similar activities, acting as a: sedative, anti-inflammatory, hypotensive, analgesic, relieving convulsions and inhibiting platelet agglutination agent [19,20,21,22].
2. Paeonia × suffruticosa as a New Pharmacopoeial Plant Species
A new raw material of the genus Paeonia, whose monograph first appeared in Supplement 9.4 to the 9th edition of European Pharmacopoeia [23] in 2018, is the root bark of Paeonia × suffruticosa Andrews-Moutan cortex. Monographs of P. × suffruticosa are also listed in the: Chinese [8], Japanese [24], Korean [25] and Vietnamese Pharmacopoeias [8], and, invariably, in the latest (10th) edition of the European Pharmacopoeia [7]. The pharmaceutical raw material is the bark of the root Paeoniae × suffruticosa cortex radicis-Moutan cortex, collected in autumn, dried, whole or broken, rubbed or not. The Chinese Pharmacopoeia distinguished the two types of P. × suffruticosa barks: Liandapi (the root is harvested in autumn, removed from the roots and soil, torn off the root bark and dried in the sun) and Guadanpi (coarse bark removed from the lignified parts and dried in the sun) [26]. Moutan cortex, according to the requirements of the European Pharmacopoeia 10th ed., should contain min. 2.2% paeonol and a minimum of 1.1% paeoniflorin [7].
TCM attributes Moutan cortex with the following effects: antipyretic, regulating menstrual disorders, accelerating the healing of ulcers, improving blood circulation and reducing swelling. In the treatment of fever, the raw material of peony root bark is administered in its raw form, while its alcoholic solutions are used to improve circulation and remove stasis. This raw material should not be used in pregnant women and those with heavy menstruation [26].
The currently known pharmacological potential of P. × suffruticosa is undoubtedly determined by its rich chemical composition. The most important groups of secondary metabolites are phenolic compounds and monoterpenoid glycosides [6,27,28,29,30,31,32,33]. This species also includes triterpenoid saponins, flavonoids, phenolic acids and polysaccharides [6,32,34]. The most important compounds responsible for the valuable biological activity of the raw material are paeonol (phenolic compound) and paeoniflorin (monoterpenoid glycoside), and partly, also 1,2,3,4,6-penta-O-galloyl-β-D-glucopyranose [6].
Currently, valuable scientific publications focus on the increasing pharmacological action of the extract, mainly from Moutan cortex, as well as the compounds present in it. They include research on, among others, antioxidant, anti-inflammatory, cytoprotective, anti-cancer and neuroprotective activities [19,20,35,36,37,38,39,40,41,42,43,44,45,46,47,48,49,50,51,52,53,54,55,56,57,58,59,60,61,62,63,64,65,66,67,68,69]. Other studies also include activities which are important due to modern civilization’s diseases, such as cardioprotective and anti-atherosclerotic, anti-diabetic and hepatoprotective effects [21,34,70,71,72,73,74,75,76,77,78,79,80,81,82,83,84,85].
P. × suffruticosa bark root extracts also have scientifically proven cosmetic properties, such as: antioxidant, anti-aging and skin brightening [86,87]. Recent reports revealed paeonol from P. × suffruticosa exhibited good effects on chronic dermatitis, such as atopic dermatitis (AD) and psoriasis [88].
The aim of this work is to deeply characterize the species, with a particular focus on biological activity, with potential applications in medicine, pharmacy and cosmetology based on scientific reports.
3. Paeonia × suffruticosa—General Characteristics
Paeonia × suffruticosa Andrews belongs to the Paeoniaceae family [89]. Throughout the world, it is known as: moutan, moutan peony, tree peony (English), Strauch-Pfingstrose (German), Mudan (Chinese) and moran (Korean) [2]. P. × suffruticosa is a plant known by numerous Latin synonymous names, such as: P. × arborea C.C.Gmel., P.× chinensis Oken, P. × fruticosa Dum. Cours., P. × moutan Sims, P. × moutan var. anneslei Sabine, P. × moutan var. papaveracea (Andrews) DC., P. × papaveracea Andrews, P. × suffruticosa f. anneslei (Sabine) Rehder, P. × suffruticosa var. banksii (Sabinene) L.H. Bailey, P. × suffruticosa var. humei (Sabinene) L.H. Bailey, P. × suffruticosa f. maculata Hong C. Zheng, P. × suffruticosa var. papaveracea (Andrews) Kern., P. × suffruticosa var. purpurea Andrews, P. × suffruticosa f. rubida Hong C. Zheng and P. × yunnanensis W.P. Fang [2].
The word “moutan” is of Chinese origin, and means “chat” or “short conversation”. It was first used in the name of the raw material in 1808 and was fixed in botanical nomenclature in the 2nd edition of the English Hortus Kewensis [89,90]. P. × suffruticosa, in Chinese colloquial language, is also called “mudan”, and is just as famous for its ornamental as well as its medicinal uses: its flower is a symbol of elegance and prosperity, while its bark root, namely “mudanpi” in Chinese, is broadly used in TCM as an adjuvant for cardiovascular and gynecological diseases [91,92,93].
Botanically and genetically, P. × suffruticosa is a very interesting and not fully understood plant. In 2001, the contemporary British taxonomist S. G. Haw [89] described P. × suffruticosa as a hybrid, but this was not supported by any evidence. Genetic analysis has shown that the five species from the subsection together constitute the origin of the tree peony varieties that arose before World War II. P. cathayana is indicated as the primary maternal species due to studies in which three-quarters of the fifty subjects have the same chloroplast DNA as this species. The remaining cultivars have chloroplast DNA identical to P. qiui, rarely from P. ostii and partly from P. rotundiloba. However, in nuclear DNA, homology with P. rockii is greatest, with P. qiui, P. ostii, P. cathayana and P. jishanensis to a lesser extent [89,94].
P. × suffruticosa is a shrubby plant reaching from 1 up to 4 m in height. The proximal leaves are doubly tripartite, and the terminal leaves are divided into three lobes, which divide into another two to three lobes, each ending in a sharp apex. The leaves are ovate or longitudinally ovate in shape, measuring 4.5–8 by 2.5–7 cm. Both surfaces of the leaf blade are smooth. Flowers are large, single (in cultivated varieties sometimes double), 10–17 cm wide and set directly on the stem. The flower has five green, broadly ovate and irregular calyx sepals each. The petals of the flower corolla are inversely ovate in shape and measure 5–8 by 4.2–6 cm. In single flowers, petals occur in number from 5 to 11; they are white, pink, red or reddish-purple in color. The circular flower base is purple in color. The plant blooms from April to May. It bears fruit in August [89]. The root extends over 1 m into the ground and is 5–12 mm in diameter and 1–4 mm thick. The outer surface is grayish-brown or yellowish-brown, with numerous transverse protrusions; it is pink when the bark falls off. The inside is pale grayish-yellow or pale brown, with distinct fine longitudinal stripes, usually with pale crystals [26].
4. Paeonia × suffruticosa—Phytochemical Characteristics
To date, about 119 compounds have been isolated and identified from the bark of P. × suffruticosa root—Moutan cortex, with phenolic compounds and monoterpenoid glycosides being the predominant compounds among them (Table 1) [29,94,95,96,97,98,99,100,101].
Table 1.
Group of Compounds | Compounds | References |
---|---|---|
Terpenoid compounds |
Monoterpenenoids deoxypaeonisuffrone, isopaeonisuffral, 6-methoxy-paeoniflorigenone, 3-O–methylpaeonisuffral, paeonifloringenone, paeoniflorin A, paeonisothujone, paeonisuffral, paeonisuffrone, (-)-paeonisuffrone Monoterpenenoid glycosides: benzoylpaeoniflorin, α-benzoyloxypaeoniflorin, β-benzoyloxypaeoniflorin, 8-O-benzoylpaeonidanin, 9-O-butyloxypaeonidanin, 4-O-butyloxypaeoniflorin, 9-O-butylpaeonidanin, 4-O-butylpaeoniflorin, 8-O-debenzoylpaeoniflorin, galloyloxypaeoniflorin, galloylpaeoniflorin, p-hydroxylbenzoylpaeonidanin, 4-methylbenzoyloxypaeoniflorin, 4-methylgalloyloxypaeoniflorin, 4-methylmoudanpioside C, 4-methyloxypaeoniflorin, 4-methylsuffrupaeoniflorin B, 4-O-methylpaeoniflorin, 4-O-methylbenzoylpaeoniflorin, mudanpioside A-J, oxypaeonidanin, 9-epi- oxypaeonidanin, oxypaeoniflorin sulfonate, paeonidanin A and C, paeoniflorin, paeoniflorin B, paeoniflorin-4-ethyl ether, paeoniside A and B, suffrupaeonidanin A-F, suffrupaeoniflorin A and B, suffruyabiosides A and B, 6-O-vanillyoxypaeoniflorin Triterpenoids: betulinic acid, mudanpinoic acid A, oleanolic acid, palbinone, ursolic acid |
[6,27,28,29,30,31,32] |
Triterpenoid saponins | hederagenin, 30-norhederagenin | [6] |
Acetophenons | 2,3-dihydroxy-4-methoxyacetophenone, gallacetophenone, p-hydroxyacetophenone, 3-hydroxy-4-methoxyacetophenone, reacetophenone | [33] |
Phenols and their derivatives | apiopaeonoside, galusan metylu, iriflophenone 2-O-β-D-glucopyranoside, methyl 3-hydroxy-4-methoxybenzoate, mudanoside C, paeonol, paeonolide, paeoniside, phenol, suffruticosides A–E | [6,33] |
Flavonoids | apigenin 7-O-rhamnoside, isorhamnetin 3,7-di-O-glucoside, quercetin, kaempferol, kaempferol 3,7-di-O-glucoside, quercetin 3-O-galloylglucoside | [6,32] |
Phenolic and cyclohexanecarboxylic acids | gallic acid, galloylquinic acid, trans-caffeic acid stearyl ester, quinic acid, p-hydroxybenzoic acid, 3-hydroxy-4-methoxybenzoic acid | [32] |
Resveratrol oligomers | suffruticosol A, suffruticosol B, suffruticosol C, trans-gnetin H, trans-suffruticosol D, trans-ε-viniferin | [63] |
Catechins | catechin, (+)-catechin-7-O-glucopyranoside, dimeric proanthocyanidin epicatechin-(4β-8)-catechin, epicatechin-3-O-gallate, flavan-3-ols catechin, epigallocatechin gallate | [104] |
Sterols | campesterol, daucosterol, β-sitosterol | [6,31] |
Polysaccharides | polisacharyd-2b | [34] |
Others | adenosine, ainsliaside E, 1,2,3,4,6-penta-O-galloyl-β-D-glucopyranose, paesuffrioside, trigalloilo-glucose, thymidine, 1-tryptophan, uridine | [30] |
The main and characteristic compound of the raw material is the phenolic compound paeonol (2′-hydroxy-4′-methoxyacetophenone, peonol) and its glycosides, such as: paeonoside, paeonolide, apiopaeonoside and suffruticosides A-E (Figure 1). Among the monoterpenoid glycosides in the species P. × suffruticosa, several pairs of isomers have been identified, including α- and β-benzoylpaeoniflorin and benzoylpaeoniflorin and paeonioside A. The common compounds in all species of the genus Paeonia include terpene glycoside paeoniflorin (Figure 2) and its analogues (oxypaeoniflorin, albiflorin, galloylpaeoniflorin, galloyloxypaeoniflorin, benzoylpaeoniflorin, mudanpioside A-J, α-benzoyloxypaeoniflorin, β-benzoyloxypaeoniflorin, 6-O-vanillyoxypaeoniflorin, suffrupaeonidanin A-F, paeonidanin A and C, suffruyabiosides A and B, paeoniside A and B, suffrupaeoniflorin A and B, oxypaeonidanin, 9-epi-oxypaeonidanin, 8-O-benzoylpaeonidanin, 9-O-butyloxypaeonidanin, 9-O-butylpaeonidanin, p-hydroxylbenzoylpaeonidanin, 4-O-methylsuffrupaeoniflorin B, paeoniflorin-4-ethyl ether, 4-O-butylpaeoniflorin, 4-O-methylmoudanpioside C, 4-O-methylbenzoyloxypaeoniflorin, oxypaeoniflorin sulfonate, 4-O-methyloxypaeoniflorin, 4-O-methylgalloyloxypaeoniflorin, 4-O-butyloxypaeoniflorin, 4-O-methylpaeoniflorin, 8-O-debenzoylpaeoniflorin, 4-O-methylbenzoylpaeoniflorin) with a specific structure, the so-called “cage-like pinnae skeleton” [102].
Acetophenones are also characteristic compounds of P. × suffruticosa, such as: 2,3-dihydroxy-4-methoxyacetophenone, gallacetophenone, p-hydroxyacetophenone, 3-hydroxy-4-methoxyacetophenone and reacetophenone (Figure 3). Noteworthy compounds also include peonisotujone and peonisuffrone (a tricyclic compound). Peonisotujone is the first identified compound of natural origin with an ortho-menthane-type monoterpenoid structure having a cyclopropane ring [31]. Additionally the presence of a specific structure, 1,2,3,4,6-penta-O-galloyl-β-D-glucopyranose (Figure 4), which plays a significant role determining the biological activity of the raw material, was found in the root [27,28,103].
In extracts of flowers’ characteristic compounds are terpenes, alcohols, alkanes, alkenes and alkatriens. The main monoterpenes are (Z)-β-ocimene, alloocimene, citronellol, citronellyl acetate, α-pinene and linalool [105,106]. In addition to the above-mentioned compounds, the presence of monoterpene glycosides, phenols, phenolic acids, tannins, flavonoids, irydoid glycosides, amino acids and sugars was confirmed in ethanol extracts from flowers [107]. The chemical composition of P. × suffruticosa flowers was presented in Table 2.
Table 2.
Group of Compounds | Compounds | References |
---|---|---|
Monoterpenoids | 3-carene, citronellal, citronellol, citronellyl acetate, nerol, allo-ocimene, β-ocimene, (E)-β-ocimene, (Z)-β-ocimene, O-cymene, β-cymene, (E)- geraniol, (Z)- geraniol, cis-linalool oxide, linalool, trans-linalool oxide (furanoid) β-myrcene, α-phellandrene, α-pinene, (1s)-(-)-β-pinene, α-terpinolene, α-terpineol |
[105,106] |
Monoterpenoid glycosides | benzoylpaeoniflorin, benzoyloxypaeoniflorin, debenzoylgalloylpaeoniflorin, 8-debenzoylpaeoniflorin, galloyloxypaeoniflorin, galloylpaeoniflorin, oxypaeoniflorin, paeoniflorin, paeonolide | [107] |
Phenols and their derivatives | mudanoside A, mudanpioside C, mudanpioside E, mudanpioside H, mudanpioside J, paeonol | [107] |
Sesquiterpenoids | β-cadinene, cis-calamenene, caryophyllene, β-copaene, α-cubebene, α-farnesene, germacrene D, γ-muurolene | [105,106] |
Alcohols | 1-decanol, 2-ethyl hexanol, cis-3-hexen-1-ol, 1-nonanol, cis-3-nonen-1-ol | [105,106] |
Alkanes | 1-chloro-octadecane, cyclotetradecane, dodecane, eicosane, heptadecane, hexadecane, 8-hexylpentadecane, nonane, octane, tetradecane, undecane | [105,106] |
Alkenes | 1-pentadecene | [105,106] |
Alkatrienes | 3,4-dimethyl-2,4,6-octatriene, (E)-4,8-dimethylnona-1,3,7-triene, 1,3,8-triene-p-menthatriene, 1,5,8-triene-p-menthatriene | [105,106] |
Adehydes | benzeneacetaldehyde, decanal, geranial, heptanal, myrtanal, neral, octanal | [106] |
Phenolic acids | gallic acid, gallic acid-di-O-glucoside, gentisic acid-5-O-glucoside, p-hydroxybenzoic acid | [107] |
Tannins | glucogallin | [107] |
Flavonoids | apigenin, apigenin-7-O-glucoside, chrysoeriol, 6,3′-dimethoxyquercetin-di-O-glucoside, diosmin, eriodictyol-7-O-glucoside, hederagenin, isorhamnetin-3-O-glucoside, isorhamnetin-7-O-glucoside, isorhamnetin-3,7-di-O-glucoside, kaempferol-3-O-(2′’-O-galloyl)-glucoside, kaempferol-3-O-glucoside, kaempferol-3-O-rutinoside, kaempferol-3,7-di-O-glucoside, luteolin, monoxerutin, patuletin-3,5-di-O-glucoside, rhoifolin, quercetin-3-O-glucoside, quercetin-O-di-glucoside | [107] |
Iridoid glycosides | geniposide, loganin, morroniside | [107] |
Furans | 2-pentylfuran | [106] |
Aminoacids | leucine, tryptophan | [107] |
Sugars | sucrose | [107] |
Seed oil of P. × suffruticosa contains mainly linolenic acid, linoleic acid, oleic acid and palmitic acid. Linolenic acid and linoleic acid together accounted for more than 60%, indicating that P. × suffruticosa seed oil can serve as a good dietary source of polyunsaturated fatty acid. On the contrary, arachidic acid, palmitoleic acid and gadoleic acid were present in smaller amounts. P. × suffruticosa seed oil also contains tocopherols (α-tocopherol, γ-tocopherol, δ-tocopherol), sterols (campesterol, stigmasterol, β-sitosterol, Δ-5-avenasterol, brassicasterol, fucosterol) and squalene [108].
5. Paeonia × suffruticosa-Studies on Biological Activity
5.1. Antioxidant Effect
Phenolic compounds found in Moutan cortex are mainly responsible for the antioxidant activity of the raw material.
Ethanolic extract of Moutan cortex at a concentration of 1 mg/mL reduces the production of reactive oxygen species (ROS) and oxidative stress-induced cytotoxicity in PC12 cells (rat adrenal pheochromocytoma cells) by enhancing the expression of genes for, among others, catechol-O-methyltransferase and hemoxygenase, which are involved in the regulation of cell cycle and free radical production [45].
The antioxidant effect was also confirmed in studies on mice exposed to cigarette smoke for 4 weeks, which caused inflammatory infiltration of the lungs, increased permeability of pulmonary vessels and increased levels of chemokines, cytokines and 4-hydroxynonenal (a biomarker of oxidative stress) in the lungs. Chronic treatment with peonol suppressed the aforementioned symptoms. In addition, extended studies on human bronchial epithelial cells showed that paeonol treatment reduced extracellular and intracellular ROS levels, inhibited mitogen-activated kinase (MAPK/NF-κB) signaling and reduced interleukin-8 (IL-8) levels induced by cigarette smoke extract [56].
In another study, a beneficial combined effect of paeonol (at a dose of 80 mg/kg) and 3-(3,4-dihydroxyphenyl)-2-hydroxypropionic acid (danshensu, the main component of Salviae milthiorrhizae radix at a dose of 160 mg/kg) was demonstrated in cases of isoproterenol-induced rat myocardial infarction (85 mg/kg). The authors of the study concluded that the mechanism of this effect may be related to the enhancement of antioxidant activity through activation of Nrf2 transcription factor signaling that controls the expression of genes encoding enzymes and cytoprotective proteins [64] (Table 3).
Table 3.
Activity | Mechanism of Action | References |
---|---|---|
Antioxidant activity | Reduction in the production of reactive oxygen species (ROS) (ethanolic extract of Moutan cortex) | [45] |
Activation of the signaling of the transcription factor Nrf2, that controls the expression of genes encoding enzymes and cytoprotective proteins (paeonol) | [56,64] | |
Cytoprotective activity | Protection of thymocytes (“pre-T lymphocytes”) against oxidative damage caused by 60Co radiation (paeoniflorin) | [38] |
Protection of human cell lines (EA.hy926) against gamma-induced oxidative damage via the transcription factor pathway protection Nrf2/HO (paeoniflorin) | [39] | |
Protection of the retinal pigment epithelium cells against oxidative stress, reduction in the production of ROS and inhibition of the activation of the caspase-3 pathway (paeoniflorin) | [40] | |
Protection against damage and cell death caused by hydrogen peroxide in human HaCaT keratinocytes (galloilopaeoniflorin) | [41] | |
Anti-inflammatory activity | Inhibition of the expression of nitric oxide synthase (iNOS) and induced cyclooxygenase (COX-2) by suppressing the phosphorylation of the inhibitory protein (I-κBα), the transcription factor NF-κB (extract of Moutan cortex) | [20] |
Inhibition of the HMGB1-RAGE/TLR-2/TLR-4-NF-κB pathway (paeoniflorin) | [66] | |
Inhibition of the synthesis of tumor necrosis factor (TNF-α) and the production of interleukin-6 (IL-6) in synoviocytes (cells of the synovial membrane of the joint capsule) (paeonol, paeoniflorin, 1,2,3,4,6-penta-O-galloyl- β-D-glucopyranose) | [67] | |
Inhibition of the secretion of interleukin-8 (IL-8) and monocyte chemotactic protein in human monocytic cells (U937) (methanol extract from shoulder) regulating the production of TNF-α and interleukins-IL-1β, IL-6 and IL-10 by inactivating I-κBα (NF-κB inhibitory protein), extracellular signal regulated kinase (ERK1/2), N-kinases c-JUN terminal (JNK) and mitogen-activated protein kinases (p38 MAPK) (paeonol) | [69] | |
Inhibition of the total expression of HMGB1, NF-κB P65 and TNF-α in the lung tissue of acute lung injury rats (paeonol) | [35] | |
Suppressing the activity of M1 macrophage cells (pro-inflammatory) and increasing the function of M2 macrophage cells (anti-inflammatory) (paeoniflorin) | [36] | |
Inhibition expressions of Il-6, TNF-α, NADPH oxidase 2 (NOX2), prostaglandin-endoperoxide synthase 2 (PTGS2), nucleobindin-2 (NUCB2)/nesfatin-1, intercellular adhesion molecule 1 (ICAM -1), vascular cell adhesion molecule 1 (VCAM-1), matrix metalloproteinase-3/13 (MMP-3/13) and degradation of type II collagen (paeonol) | [37] | |
Anticancer activity | Reduction resistance to paclitaxel in human breast cancer cells by regulating the expression of transgelin 2 (paeonol) | [42] |
Induction of an anti-tumor effect on colon cancer cells by suppressing prostaglandin synthesis (PGE-2) and expression of COX-2 (paeonol) | [43] | |
Inhibition of the metastasis of melanoma and chondrosarcoma (paeonol) | [44] | |
Induction of apoptosis of EMT6 breast cancer cells, HepG2 human liver cancer cells and HepA cells in a mouse model (paeonol) | [46,48] | |
Inhibition of cell proliferation and induction of apoptosis on mouse gastric cancer cell lines (MFC) and on human gastric tumor cells SGC-7901 (paeonol) | [49] | |
Decreases the expression of proteins regulating the release of cytochrome c from mitochondria (Bcl-2) and increased the expression of the apoptosis accelerating protein (Bax) in MFC and SGC-7901 (paeonol) | [49] | |
Cells’ suppression of the signaling pathway for the gene encoding the single-pass Notch-1 transmembrane receptor in breast cancer cells (paeoniflorin) | [50] | |
Inhibition of macrophage-dependent metastasis of lung cancer (paeoniflorin) | [50] | |
Inhibition of proliferation and induction of apoptosis of human glioblastoma cells by up-regulation of microRNA-16 and down-regulation of metalloproteinase-9 (paeoniflorin) | [51] | |
Reduction in proliferation on human SK-HEP-1 hepatocellular carcinoma cells (1,2,3,4,6-penta-O-galloyl-β-D-glucopyranose) | [52] | |
Inhibition of the growth of bladder cancer cells (extract of Moutan cortex) | [53] | |
Induction stress on endoplasmic reticulum (ER)-related proteostasis and affected mitochondrial membrane potential to increase autophagosome numbers and block their degradation (aqueous extracts of Moutan cortex) | [54] | |
Inhibition of the proliferation of human liver cancer cell line (HepG2) and human hepatocarcinoma cell line (SMMC-7721) and induction apoptosis, concomitant with the down-regulation of survivin (paeonol) | [55] | |
Cardioprotective and anti-atherosclerotic activity | Inhibition of thrombocyte aggregation and blood coagulation (paeonol, paeoniflorin, benzoylpaeoniflorin and benzoyloxypaeoniflorin) | [21] |
Protective effect in the rat model of ischemia and reperfusion (extract of Moutan cortex) | [78] | |
Inhibition of inflammatory processes and signaling pathways of iNOS (paeoniflorin) | [79] | |
Reduction in vascular damage and the expression of E-selectin and intercellular adhesion molecule (ICAM-1) in a mouse model of the skin Arthus reaction (paeoniflorin) | [80] | |
Increases thrombus recanalization by inducing endothelial growth factor-165 and up-regulating urokinase plasminogen activator (paeonol and paeoniflorin) | [81,82] | |
Inhibition of the adhesion of monocytes, induced by the oxidized form of LDL, to the vascular endothelium by inhibiting the mitogen-activated kinase (MAPK) signaling pathway (paeonol) | [83] | |
Prevention arterial thrombosis (paeoniflorin) | [84] | |
Antidiabetic activity | Inhibition of glucose uptake by intestinal brush border membrane vesicles (BBMV) and increased glucose uptake in human skin fibroblasts (Hs68) and Mouse adipocytes (3T3-L1) (extract of Moutan cortex) | [85] |
improved glucose tolerance (paeonol) | [85] | |
Decrease in receptor expression for glycation products and NF-κB in the hippocampus and cortical neurons of the brain (paeonol) | [70] | |
Increases the content of glutathione and noticeably reduces the activity of iNOS in the tissue of the hippocampus (paeonol) | [71] | |
Delays the onset and alleviates the degree of lens opacities in diabetic cataracts (polysaccharide-2b present Moutan cortex) | [34] | |
Stimulation of human insulin-resistant HepG2 cells glucose uptake and glycogen synthesis via the AMPK pathway (palbinon and some triterpenoids isolated from Moutan cortex) | [72] | |
Neuroprotective activity | Relieving neuropathic pain (Moutan cortex extract) | [19] |
Protective effect on neurons in a mouse model of Parkinson’s disease (Moutan cortex extract) | [57] | |
Reduction in cell damage and extending cell viability by inhibiting the ability to bind the N-methyl-D-aspartate (NMDA) receptor and reducing the intracellular concentration of calcium ions (paeonol) | [59] | |
Suppression of neuroinflammatory reactions by suppressing the NF-κB pathway and mitogen-activated kinases (MAPK) (paeonol) | [59] | |
Inhibition of the release of NO and the expression of iNOS and COX-2 in microglia cells (paeonol) | [60] | |
Regulation of AMPK-α kinase and glycogen synthase 3α/β kinase (GSK 3α/β) (paeonol) | [60] | |
Protection of nerve cells against oxidative stress by inducing the expression of the hemoxygenase-1 gene (1,2,3,4,6-penta-O-galloyl-β-D-glucopyranose) | [62] | |
Improves the cognitive performance of scopolamine-treated mice in behavioral tests (seed coat extracts of P. × suffruticosa) | [63] | |
Increases acetylcholinesterase, choline acetyltransferase, superoxide dismutase (SOD) and catalase (CAT) activities and acetylcholine, glutathione (GSH) and IL-4 levels, and decreases IL-1β, IL-6 and TNF-α levels in a cell line that was derived from a transplantable rat pheochromocytoma (seed coat extracts of P. × suffruticosa) | [63] | |
Activity in neurodegenerative diseases | Increasing the level of acetylcholine and GSH (paeonol) | [22] |
Restoration of superoxide dismutase activity and concentration of Na +/K+-ATPase (paeonol) | [110] | |
Reduction in MDA levels and cholinesterase activity (paeonol) | [110] | |
Alleviated neuronal damage, both in the hippocampus and in the temporal cortex (paeonol) | [110] | |
Inhibition of formation and destabilization of initial formation of amyloid-β fibrils in in vitro and in vivo models (1,2,3,4,6-penta-O-galloyl-β-D-glucopyranose) | [111] | |
Hepatoprotective activity | Reduction in GSH deficit, cytochrome P450 2E1 activity and protection against damage to hepatic DNA (extract of Moutan cortex) | [73,74,75,76,77] |
Decrease in serum transaminase levels, damage to liver cells, steatosis and infiltration of inflammatory cells (paeonol) | [74] | |
Reduction in hepatic mRNA expression of lipogenic genes (paeonol) | [74] | |
Lowering the level of inflammatory cytokines in serum and tissues, peroxidation of tissue lipids, neutrophil infiltration and inhibition of hepatocyte apoptosis (paeonol) | [75] | |
Alleviation of liver fibrosis by inhibiting the hypoxia-1α-induced factor, partly by the m-TOR dependent pathway (paeoniflorin) | [76,77] | |
Anti-allergic effect | Inhibition of systemic anaphylactic shock (ethanol extract of Moutan cortex) | [112] |
Inhibition of the scratch reflex (ethanol extract of Moutan cortex) | [112] | |
Inhibition of increased vascular permeability (ethanol extract of Moutan cortex) | [112] | |
Reduction in histamine release from mast cells (ethanol extract of Moutan cortex) | [113] | |
Immunomodulatory activity | Stimulation of Raw264.7 (macrophage cell line) cell proliferation (polysaccharides obtained from P. × suffruticosa flowers) | [114] |
Activation of Raw264.7 cells by releasing immunoactive molecules such as NO, TNF-α and IL-6 (polysaccharides obtained from P. × suffruticosa flowers) | [114] | |
Antibacterial and antifungal activity | Inhibition of growth of Gram-positive bacteria: Staphylococcus aureus and Gram-negative bacteria: Escherichia coli (methanol extract of Moutan cortex) | [32,116] |
Inhibition of growth of Candida glabrata (1,2,3,4,6-penta-O-galloyl-β-D-glucopyranose) | [116] |
5.2. Cytoprotective Effect
Scientific studies prove the cytoprotective effect of paeoniflorin isolated from the Moutan cortex. Paeoniflorin (50–200 µg/mL) protected thymocytes (“pre-T lymphocytes”) from 60Co radiation-induced oxidative damage [38]. Another study showed that peoniflorin protected human cell lines (EA.hy926) from gamma radiation-induced oxidative damage through the Nrf2/HO transcription factor pathway [39]. In addition, some studies also suggest that paeoniflorin protects retinal pigment epithelial cells from oxidative stress by reducing ROS production and inhibiting activation of the caspase-3 pathway [40].
Moreover, studies conducted on different concentrations (1, 5, 10 or 20 μM) of galloylopaeoniflorin (a derivative of paeoniflorin) showed cytoprotective activity at 20 μM against hydrogen peroxide-induced cell damage and death in human keratinocytes HaCaT [41] (Table 3).
5.3. Anti-Inflammatory Effect
Studies conducted both in vitro and in vivo on the anti-inflammatory activity of Moutan cortex indicated that two compounds—paeonol and paeoniflorin—are mainly responsible for this effect.
Studies conducted with Moutan cortex extracts at concentrations of 0.1 and 0.3 mg/mL on regulatory mechanisms of cytokine and nitric oxide production, involved in immune activity of mouse macrophage/monocyte RAW264.7 cells, showed inhibition of nitric oxide synthase (iNOS) and inducible cyclooxygenase (COX-2) expression by suppressing phosphorylation of the inhibitory protein (I-κBα) transcription factor NF-κB [20].
Another study focused on gene expression changes in cultures of human gingival fibroblasts stimulated by lipopolysaccharides (LPS). The results suggested that a crude extract containing paeonol and paeoniflorin blocked the induction of inflammation by comprehensively inhibiting the activation of multiple genes associated with the formation of inflammation [65].
It was also demonstrated that paeoniflorin added at various concentrations (1, 10 or 100 µmol/L) 2 h before exposure to 10 mg/L lysophosphatidylcholine (LPC) for 24 h inhibits the production of inflammatory factors in LPC-induced human umbilical vein endothelial cells by inhibiting the HMGB1-RAGE/TLR-2/TLR-4-NF-κB pathway [66].
Studies of paeonol, paeoniflorin and 1,2,3,4,6-penta-O-galloyl-β-D-glucopyranose confirmed their inhibitory effects on tumor necrosis factor (TNF-α) synthesis and interleukin-6 (IL-6) production in synoviocytes (synovial membrane cells of the joint capsule) treated with pro-inflammatory agents in a dose-dependent manner [67].
Studies have shown that a methanolic extract of Moutan cortex, particularly 1,2,3,4,6-penta-O-galloyl-β-D-glucopyranose, inhibits IL-8 and monocyte chemotactic protein secretion in human monocytic cells (U937) stimulated with phorbol myristate acetate [68].
The anti-inflammatory effect of paeonol (at doses 150, 200 or 250 mg/kg) was also demonstrated by inhibiting inflammatory cytokines in lipopolysaccharide (LPS)-induced macrophage cells in mice. In addition, paeonol protected mice from lethal endotoxic shock. In vitro studies showed that paeonol regulated the production of TNF-α and the interleukins IL-1β, IL-6 and IL-10 through inactivation of I-κBα (NF-κB inhibitory protein), extracellular signal-regulated kinase (ERK1/2), c-JUN N-terminal kinase (JNK) and mitogen-activated protein kinase (p38 MAPK) [69].
Treatment with paeonol significantly improved the survival rate and mean arterial pressure (MAP) and attenuated the pathological damage to the lung tissue in acute lung injury rats. Western blotting revealed that paeonol also inhibited the total expression of HMGB1, NF-κB P65 and TNF-α in the lung tissue of acute lung injury rats. Moreover, paeonol increased the expression of HMGB1 in the nucleus, inhibited the production of HMGB1 in the cytoplasm and decreased the expression of P65 both in the nucleus and cytoplasm of lung tissue cells in LPS-induced acute lung injury rats. These findings indicate that paeonol may be a potential treatment for acute lung injury through its repression of the HMGB1-NF-κB P65 signaling pathway [35].
Examination of paeoniflorin on the activity of M1 pro-inflammatory and M2 anti-inflammatory macrophages showed that the compound can suppress the activity of M1 cells while increasing the function of M2 cells. This action can be used to treat autoimmune and autoinflammatory diseases [36].
The studies on chondrogenic cell line ATDC5 cells cultured with IL-1b showed that peonol from P. × suffruticosa inhibits numerous factors of osteoarthritis, including expressions of IL-6, TNF-α, NADPH oxidase 2 (NOX2), prostaglandin–endoperoxide synthase 2 (PTGS2), nucleobindin-2 (NUCB2)/nesfatin- 1, intercellular adhesion molecule 1 (ICAM-1), vascular cell adhesion molecule 1 (VCAM-1), matrix metalloproteinase-3/13 (MMP-3/13) and degradation of type II collagen [37] (Table 3).
5.4. Anticancer Effect
Many experiments on the anticancer properties of the raw material have been based on studies of the isolated compounds, paeonol and paeoniflorin. It was demonstrated that paeonol reduces paclitaxel resistance in human breast cancer cells by regulating the expression of transgelin 2 [42] and also exerts an anti-cancer effect on colon cancer cells by suppressing prostaglandin (PGE-2) synthesis and COX-2 expression. In addition, paeonol inhibits metastasis of melanoma [43] and chondrosarcoma [44] and, at doses of 150 and 300 mg/kg, induces apoptosis of EMT6 breast cancer cells [46] at concentrations (7.81–250 mg/L) of human HepG2 liver cancer cells [47] and at doses of 100, 200 or 400 mg/kg/day of HepA cells in a mouse model [48].
In studies on mouse forestomach carcinoma (MFC) cell lines and on SGC-7901 human gastric cancer cells, paeonol was shown to cause dose-dependent inhibition of cell proliferation and induction of apoptosis. Cell cycle analysis showed reduced cell proliferation in G/G1 phase, with arrest in S phase. In MFC and SGC-790 cells, paeonol significantly decreased the expression of proteins that regulate the release of cytochrome c from mitochondria (Bcl-2) and increased the expression of apoptosis-accelerating protein (Bax) in a concentration-dependent manner. Administration of paeonol to mice with an MFC tumor significantly reduced tumor growth and caused its regression [49].
Studies demonstrated that paeoniflorin inhibits the proliferation and invasion of breast cancer cells by suppressing the signaling pathway for the gene encoding the Notch-1 single-pass trans-membrane receptor [109] and inhibits the macrophage-dependent metastasis of lung cancer [50]. In addition, paeoniflorin at concentrations of 10 and 20 μM inhibits proliferation and induces apoptosis of human glioma cells through up-regulation of microRNA-16 and down-regulation of metalloproteinase-9 [51].
In vitro studies of 1,2,3,4,6-penta-O-galloyl-β-D-glucopyranose isolated from Moutan cortex showed its antiproliferative activity on human hepatocellular carcinoma cell line SK-HEP-1 [52].
Scientific studies further showed that Moutan cortex extracts show greater selectivity in inhibiting growth against bladder cancer cells than mitomycin C, doxorubicin or cisplatin. The raw material also reduced the expression of angiogenesis-stimulating factors, including vascular endothelial growth factor (VEGF) [53].
Aqueous extracts of P. × suffruticosa were tested for action on pancreatic cancer cell line PANC1 and in vivo in mouse xenograft tumors. The extracts induced stress on endoplasmic reticulum (ER)-related proteostasis and affected mitochondrial membrane potential to increase autophagosome numbers and block their degradation, followed by autophagy induction and, finally, cell apoptosis. Nevertheless, oral administration of P. × suffruticosa aqueous extracts, alone or in combination with gemcitabine in mice, delayed tumor growth in a xenograft model without affecting body weight [54].
Another study demonstrated that paeonol can exert antitumor effects on hepatocellular carcinoma (HCC) cells by targeting survival via the COX-2/PGE2 signaling pathway. Peonol significantly inhibited the proliferation of human liver cancer cell line (HepG2) and human hepatocarcinoma cell line (SMMC-7721) and induced apoptosis, concomitant with the down-regulation of survival. The levels of COX-2 and PGE2 were also reduced by paeonol [55] (Table 3).
5.5. Cardioprotective and Anti-Atherosclerotic Effects
Scientific studies of isolated compounds present in both Paeoniae alba radix and Moutan cortex for their anti-aggregation and anti-coagulation properties showed that paeonol, paeoniflorin, benzoylpaeoniflorin and benzoyloxypaeoniflorin are the main compounds that together can contribute to improving blood circulation. These compounds had an inhibitory effect on thrombocyte aggregation and blood coagulation. In addition, it is possible that other compounds in the raw materials, i.e., methyl gallate, (+)-catechin, paeoniflorigenone, galloylpaeoniflorin and daucosterol may also be involved in improving circulation [21].
Another study showed that Moutan cortex extract administered at a dose of 1.98 g/kg for 14 days exerts a protective effect in a rat model of ischemia and reperfusion [78].
Studies of paeoniflorin administered at doses of 5, 10 and 20 mg/kg confirmed its ability to alleviate acute myocardial infarction in rats by inhibiting inflammatory processes and nitric oxide synthase (iNOS) signaling pathways [79]. It was also demonstrated that paeoniflorin reduces vascular damage and the expression of E-selectin and the intercellular adhesion molecule (ICAM-1) in a mouse model of cutaneous Arthus reaction [80]. Paeonol and paeoniflorin enhance thrombus recanalization by inducing endothelial growth factor-165 [81] and up-regulating urokinase-type plasminogen activator, respectively [82]. In both cases, the mechanism of action was related to the mitogen-activated kinase (MAPK) signaling pathway.
It was also confirmed that paeonol prevents the development of atherosclerosis by inhibiting monocyte adhesion, induced by the oxidized form of low-density lipoprotein (LDL), to the vascular endothelium through inhibition of the mitogen-activated kinase (MAPK) signaling pathway [83].
Studies have shown that the paeoniflorin bioactive compound from P. × suffruticosa prevented arterial thrombosis in vivo from the dose of 10 mg/kg without prolonging bleeding time or blood clotting time in rats [84] (Table 3).
5.6. Antidiabetic Effect
In in vitro studies conducted on four models (intestinal brush border epithelial cells-BBMV, cells of the H4IIE (rat hepatoma) line, human fibroblast cells-Hs68 and mouse adipocytes 3T3-L1), it was shown that Moutan cortex extract and its main component, paeonol, have antidiabetic effects by inhibiting glucose uptake by intestinal brush border membrane vesicles (BBMV) and increasing glucose uptake in human skin fibroblast cells (Hs68) and mouse adipocytes (3T3-L1). Paeonol (at doses of 200 and 400 mg/kg) was also shown to improve glucose tolerance in an in vivo model [85].
In a study of encephalopathy in rats with streptozocin-induced diabetes, a significant decrease in receptor expression for glycation products and NF-κB was noted in the hippocampus and brain cortical neurons after treatment with paeonol (at doses of 50 and 100 mg/kg). In addition, peonol significantly increased glutathione content and noticeably decreased nitric oxide synthase (iNOS) activity in hippocampal tissue [70]. In another study conducted on rats with streptozocin-induced diabetes, paeoniflorin (at doses of 5, 10 or 20 mg/kg) was shown to have a preventive effect against the onset of nephropathy [71]. Subsequent studies in rats with streptozocin-induced diabetes and Freud’s complete adjuvant showed that polysaccharide-2b present in Moutan cortex could significantly delay the onset and alleviate the degree of lens opacification in diabetic cataracts. Compared to the model group, the groups treated with polysaccharide-2b had reduced levels of malonylaldehyde (MDA), and, in the groups treated with its medium and high doses, reduced levels of glutathione peroxidase, superoxide dismutase and catalase were observed, as well as increased Na+/K+ ATP-ase activity. These results indicate a positive relationship between the dose of polysaccharide-2b and its effect [34].
Palbinone and certain triterpenoids isolated from Moutan cortex stimulated glucose uptake and glycogen synthesis via the AMPK pathway in a dose-dependent manner in human insulin-resistant HepG2 cells. These compounds may have significant potential in alleviating metabolic disorders associated with diabetic complaints [72] (Table 3).
5.7. Neuroprotective Effect
Studies demonstrated that Moutan cortex is effective in alleviating neuropathic pain in mice [19] and exhibits protective effects on neurons in a mouse model of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced Parkinson’s disease [57].
In studies conducted on nerve cell cultures, paeonol at concentrations of 12.5, 25 and 50 μmol/L was shown to protect rat neurons from oxygen and glucose deficiency-induced damage. As a result, it reduces morphological damage to cells and prolongs their life span. This effect may be related to inhibition of N-methyl-D-aspartate (NMDA) receptor binding capacity and reduction in intracellular calcium ion concentration [58]. Paeonol was also confirmed to suppress LPS-induced neuroinflammatory responses through suppression of the NF-κB pathway and mitogen-activated kinase (MAPK) [59]. In studies conducted on microglia cells, paeonol significantly inhibited the release of nitric oxide (NO) and the expression of iNOS and COX-2. Paeonol treatment also reduced ROS production and inhibited excessive ATP-induced cell migration. The anti-neuroinflammatory effect of paeonol was also found to be regulated by AMPK-α kinase and glycogen synthase kinase 3 α/β (GSK 3α/β) [60].
In addition, the protective properties of paeoniflorin at doses of 5 mg/kg administered twice daily for 14 days against ischemic brain injury in rats were confirmed by inhibiting the MAPKs/NF-κB-dependent inflammatory response [61]. It was also demonstrated that 1,2,3,4,6-penta-O-galloyl-β-D-glucopyranose can protect neuronal cells from oxidative stress by inducing the expression of the hemooxygenase-1 gene [62].
Additionally, resveratrol oligomers: resveratrol trimers-suffruticosol A, suffruticosol B, suffruticosol C, trans-suffruticosol D, trans-gnetin H and resveratrol dimer-trans-ε-viniferin, found in the seed coat extracts of P. × suffruticosa, had an effect on cholinesterase and the reduction in cytotoxicity induced by oxygen and glucose reoxygenation/reoxygenation (OGD/R) in PC12 cells (cell line that was derived from a transplantable rat pheochromocytoma) and on scopolamine-induced cognitive deficits in mice. The seed coat extracts of P. × suffruticosa display good inhibition of acetylcholinesterase and butyrylcholinesterase activities and significantly increase the viability of normal and OGD/R-injured PC12 cells. The seed coat extracts of P. × suffruticosa improve the cognitive performance of scopolamine-treated mice in behavioral tests. Furthermore, the seed coat extracts of P. × suffruticosa increase acetylcholinesterase, choline acetyltransferase, superoxide dismutase (SOD) and catalase (CAT) activities and acetylcholine, glutathione GSH and iterleukin-4 (IL-4) levels and decreases interleukin-1β (IL-1β), interleukin-6 (IL-6) and TNF-α levels in the model animals [63] (Table 3).
5.8. Effects in Neurodegenerative Diseases
Studies demonstrated that paeonol treatment can protect against many of the biochemical, morphological and behavioral changes resulting from amyloid-β administration in a rat model of Alzheimer’s disease. The results suggest that paeonol is a potential therapeutic agent in slowing down the pathogenic processes associated with the disease [22]. A study conducted on ICR mice (albino mice) in a D-galactose assay injected subcutaneously for 60 days at a dose of 50 mg/kg/day showed that paeonol at 50 and 100 mg/kg, together with D-galactose, increased acetylcholine and glutathione levels, restored superoxide dismutase activity and Na+/K+-ATPase levels, and decreased MDA levels and cholinesterase activity. In addition, paeonol alleviated neuronal damage in both the hippocampus and temporal cortex [110]. It was also confirmed that 1,2,3,4,6-penta-O-galloyl-β-D-glucopyranose inhibits the formation and destabilizes the pre-formation of amyloid-β fibrils in in vitro and in vivo models [111] (Table 3).
5.9. Hepatoprotective Effect
In in vivo studies, Moutan cortex extract was proven to have a protective effect against liver damage from paracetamol. The extract reduced glutathione deficiency and cytochrome P450 2E1 activity and protected against the destruction of hepatic DNA [73].
In another experiment, the effect of paeonol on model alcoholic liver damage in mice was studied. Paeonol treatment significantly reduced serum aminotransferase levels, liver cell damage, steatosis and inflammatory cell infiltration. In addition, paeonol significantly reduced hepatic mRNA expression of lipogenic genes and serum and tissue levels of inflammatory cytokines, tissue lipid peroxidation and neutrophil infiltration and inhibited hepatocyte apoptosis [74]. In addition, paeonol was shown to attenuate epirubicin-induced hepatotoxicity by inhibiting the PI3K/Akt/NF-κB pathway [75].
Paeoniflorin (at a dose of 50 mg/kg) injected into the tail vein in a mouse model protected against concanavalin A-induced liver inflammation by inhibiting certain pro-inflammatory cytokines, i.e., TNF-α, IL-6 and IFN-γ and down-regulating the NF-κB pathway [76]. Another study showed that paeoniflorin attenuated liver fibrosis by inhibiting hypoxia-inducible factor-1α, in part through the m-TOR-dependent pathway [77] (Table 3).
5.10. Anti-Allergic Effect
The anti-allergic effect of the ethanol extract of Moutan cortex was evaluated in some animal models. The raw material extract (at 30 and 100 mg/kg, i.p.) dose-dependently inhibited systemic anaphylactic shock induced by compound 48/80 (a polymer that increases histamine release) in mice. It also dose-dependently inhibited the scratching reflex induced by compound 48/80 or histamine at a dose of 100 mg/kg b.w. Increased vascular permeability induced by compound 48/80 or histamine was also inhibited by Moutan cortex extract. In addition, in vitro, the raw material reduced histamine release from rat peritoneal cell mast cells. Aiming to test the active component of the crude extract, it was suspended in water and extracted with ethyl acetate. Fractions insoluble in acetone extract (A) and soluble in it (B) were obtained. The effect of extract (B) was stronger than that of extract (A) in inhibiting histamine release. This study indicates that the raw material may be useful in alleviating symptoms of atopic dermatitis and other allergy-related diseases [112].
In vitro and in vivo studies showed that the ethanolic extract of Moutan cortex does not cause cytotoxicity in human mast cells. The ethanolic extract of the raw material (200 mg/kg) significantly inhibited the passive cutaneous anaphylactic reaction in vivo and inhibited the histamine release induced by compound 48/80 from rat peritoneal mast cells [113] (Table 3).
5.11. Immunomodulatory Activity
Two polysaccharides (PSAP-1 and PSAP-2) obtained from P. × suffruticosa flowers were tested for activity on RAW264.7 cells (macrophage cell line). The polysaccharides were subjected to chromatographic analysis, which showed that PSAP-1 was mainly composed of glucuronic acid, glucose, arabinose and galactose, while PASAP-2 was composed of rhamnose, galacturonic acid, glucose, arabinose and galactose. Research results showed that PSAP-1 and PSAP-2 can significantly stimulate Raw264.7 cell proliferation in a dose-dependent manner and further activate Raw264.7 cells by releasing immunoactive molecules such as nitric oxide, TNF-α and IL-6. In addition, PSAP-2 had higher immunomodulatory activity than PSAP-1 [114] (Table 3).
5.12. Antibacterial and Antifungal Effects
P. × suffruticosa buds extract showed the most efficient antibacterial effect against Staphylococcus aureus and E. coli, for which the minimum inhibition concentration (MIC) and minimum bactericide concentration (MBC) both were 1.56 mg/mL and 6.25 mg/mL, respectively [32,115].
Studies have shown that Moutan cortex has antifungal activity against Candida glabrata. The compound responsible for the above activity may be 1,2,3,4,6-penta-O-galloyl-β-D-glucopyranose, due to its cell wall degradation inducing activity [116] (Table 3).
6. Applications in Cosmetology
Moutan cortex extract also has scientifically proven cosmetic effects, such as antioxidant, anti-aging and skin brightening effects [86,87]. In studies on B16 cells used to study skin cancer, the extracts were shown to inhibit tyrosinase activity and 3,4-dihydroxyphenylalanine (DOPA), which contributes to the reduction in melanin content in cells [86]. Additionally, kinetic analyses revealed that the ethanol Moutan cortex extract and paeonol are noncompetitive tyrosinase inhibitors. The cellular melanin content and L-DOPA oxidation assays demonstrated that the ethanol Moutan cortex extract was an appropriate alternative whitening agent to paeonol and arbutin in ultraviolet-induced A2058 human melanoma cells. The ethanol Moutan cortex extract was also confirmed as a promising ingredient in sun protection and skin whitening cosmetics [87]. In vitro, P. × suffruticosa root extract and paeonol significantly inhibited UVB-induced phosphorylation of mitogen-activated protein kinase and activator protein 1 in keratinocytes, which consequently led to degradation of procollagen type I. In vivo, topical application of P. × suffruticosa root extract and paeonol attenuated UVB-induced matrix metalloproteinase-1 production and promoted procollagen type I in hairless mice [117]. Recent reports revealed paeonol from P. × suffruticosa exhibited good effects on chronic dermatitis, such as atopic dermatitis (AD) and psoriasis. One study analyzed the effects of paeonol on a mouse model of dry skin treated with acetone-ether-water (AEW). The results showed impressive activities in reducing scratching behavior and skin inflammation. The studies indicated that paeonol can ameliorate AEW-induced inflammatory response and itching behavior and reduce the expression of spinal astrocyte activity-dependent genes induced by AEW, reducing the expression of spinal astrocyte activity-dependent genes induced by AEW [88].
According to the CosIng (Cosmetic Ingredient Database) [118], in addition to extracts from the root and bark of P. × suffruticosa, it is also possible to use extracts from stems, leaves, flowers, from the whole plant, as well as from the biomass of callus cultures in the production of cosmetics in the countries of the European Union (Table 4) [118]. In cosmetics, hydrolates from flowers, roots and seed oil have also found application. These raw materials can be found mainly in facial skin care cosmetics with anti-aging, antioxidant, brightening and nourishing properties. In addition to the above-mentioned properties, hydrolats also give cosmetics a pleasant fragrance. Additionally, the P. × suffruticosa root is found in the filtrates of products obtained from the fermentation of the roots of various plant species by bacteria: Acetobacter, Lactobacillus and Leuconostoc and by fungi: Aspergillus, Monascus and Saccharomyces (Table 4). Paeonia suffruticosa root extract is most commonly used in cosmetic products. It is found in Korean (e.g., A’pieu, Holika Holika), French (e.g., L’Oreal, Yves Saint Laurent, Lancôme), Polish (e.g., Dermofuture) and American (e.g., Estée Lauder) cosmetics.
Table 4.
INCI Name | Description | Functions |
---|---|---|
Paeonia × suffruticosa bark extract | The extract of the bark of the Chinese Peony, Paeonia × suffruticosa, Paeoniaceae. | Skin conditioning |
Paeonia × suffruticosa branch/flower/leaf extract | The extract of the branches, flowers and leaves of the Chinese Peony, Paeonia × suffruticosa, Paeoniaceae. | Skin conditioning |
Paeonia × suffruticosa callus extract | The extract of the callus of Paeonia × suffruticosa, Paeoniaceae. | Antimicrobial Antioxidant Hair conditioning Skin protecting |
Paeonia × suffruticosa extract | The extract of the whole plant Paeonia × suffruticosa, Paeoniaceae. | Skin conditioning |
Paeonia × suffruticosa flower extract | The extract of the flowers of Paeonia × suffruticosa, Paeoniaceae. | Skin conditioning |
Paeonia × suffruticosa flower water | The aqueous solution of the steam distillate obtained from the flowers of the Chinese Peony, Paeonia × suffruticosa, Paeoniaceae. | Fragrance |
Paeonia × suffruticosa phytoplacenta extract | The extract of the phytoplacenta cells directly isolated from Paeonia × suffruticosa or grown in culture, Paeoniaceae. | Antimicrobial Antioxidant Hair conditioning Skin conditioning |
Paeonia × suffruticosa root extract | The extract of the roots of the Chinese Peony, Paeonia × suffruticosa, Paeoniaceae. | Skin protecting |
Paeonia × suffruticosa root water | The aqueous solution of the steam distillates obtained from the roots of the Chinese Peony, Paeonia × suffruticosa, Paeoniaceae. | Flavoring Fragrance Perfuming Skin conditioning |
Paeonia × suffruticosa seed oil | The oil expressed from the seeds of Paeonia × suffruticosa, Paeoniaceae. | Skin conditioning Skin conditioning-emollient |
Aspergillus/Paeonia × suffruticosa bark/Honeysuckle flower/Forsythia fruit (Astragalus membranaceus/Gentiana scabra/Licorice/Rehmannia glutinosa/Rheum palmatum/Scrophularia buergeriana) root/(castor/rice) seed ferment extract | The extract of the product obtained by the fermentation of the bark of Paeonia × suffruticosa; the flower of Lonicera japonica (honeysuckle); the fruit of Forsythia suspensa (forsythia); the roots of Astragalus membranaceus, Gentiana scabra, Glycyrrhiza glabra (licorice), Rehmannia glutinosa (rehmannia), Rheum palmatum and Scrophularia buergeriana; the seeds of Oryza sativa (rice), and Ricinus communis (castor), by the microorganism Aspergillus. | Skin conditioning |
Lactobacillus/(Achyranthes bidentata/Angelica gigas/Angelica pubescens/Angelica tenuissima/Asarum sieboldi/Cnidium officinale/Ledebouriella divaricata/Paeonia × suffruticosa) Root/Eucommia ulmoides Bark/Magnolia liliflora Bud Ferment Filtrate | The filtrate of the product obtained by the fermentation of the roots of Achyranthes bidentata, Angelica gigas, Angelica pubescens, Angelica tenuissima, Asarum sieboldi, Cnidium officinale, Ledebouriella divaricata, Paeonia × suffruticosa, the bark of Eucommia ulmoides and the buds of Magnolia liliflora by the microorganism, Lactobacillus. | Skin conditioning-miscellaneous |
Lactobacillus/(Cudrania tricuspidata/Paeonia × suffruticosa) Bark/Lycium chinense Fruit/Apricot Kernel/Artemisia capillaris Leaf/(Angelica dahurica/Scutellaria baicalensis) Root/Soybean Seed/Houttuynia cordata/Mistletoe/Poria Cocos ferment filtrate | The filtrate of the product obtained by the fermentation of the bark of Cudrania tricuspidata, and Paeonia × suffruticosa; the fruits of Lycium chinense; the kernels of Prunus armeniaca (apricot); the leaves of Artemisia capillaris; the roots of Angelica dahurica, and Scutellaria baicalensis; the seeds of Glycine soja (soybean); the whole plants, Houttuynia cordata, and Viscum album (mistletoe); and the fungus, Poria cocos, by the microorganism Lactobacillus. | Humectant Skin conditioning |
Lactobacillus/Ledebouriella divaricate root/Angelica dahurica root/Angelica tenuissima root/Magnolia liliflora bud/Asarum sieboldin root/Paeonia × suffruticosa root/Cnidium officinale root/Angelica gigas root/Aukcklandia lappa root/Achyranthes japonica root/Eucommia ulmoides bark/Angelica pubescens root/Aconitum koreanum root ferment filtrate | The a filtrate of the product obtained by the fermentation of the roots of Ledebouriella divaricata, Angelica dahurica, Angelica tenuissima, Asarum sieboldi, Paeonia × suffruticosa, Cnidium officinale, Angelica gigas, Auklandia lappa, Achyranthes japonica, Angelica pubescens, and Aconitum koreanum, the buds of Magnolia liliflora and the bark of Eucommia ulmoides by the microorganism, Lactobacillus. | Skin conditioning |
Leuconostoc/Ledebouriella divaricata root/Angelica dahurica root/Angelica tenuissima root/Magnolia liliflora bud/Asarum sieboldi root/Paeonia × suffruticosa root/Cnidium officinale root/Angelica gigas root/Aucklandia lappa root/Achyranthes japonoica root/Eucommia ulmoides bark/Angelica pubescens root/Aconitum koreanum root ferment | The product obtained by the fermentation of the roots of Ledebouriella divaricata, Angelica dahurica, Angelica tenuissima, Asarum sieboldi, Paeonia × suffruticosa, Cnidium officinale, Angelica gigas, Aucklandia lappa, Achyranthes japonoica, Angelica pubescens, Aconitum koreanum, the buds of Magnolia liliflora, and the bark of Eucommia ulmoides, by the microorganism, Leuconostoc. | Skin Conditioning |
Monascus/Paeonia × suffruticosa flower/rice bran ferment filtrate | The filtrate of the product obtained by the fermentation of the flowers of Paeonia × suffruticosa and the bran of Oryza sativa (rice) by the microorganism, Monascus. | Anti-sebum Skin conditioning |
Acetobacter/Ledebouriella divaricata root/Angelica dahurica root/Angelica tenuissama root/Magnolia liliflora bud/Asarum sieboldi root/Paeonia × suffruticosa root/Cnidium officinale root/Angelica gigas root/Aucklandia lappa root/Achyranthes japonica root/Eucommia ulmoides bark/Angelica pubescens root/Aconitum koreanum root ferment filtrate | The filtrate of the product obtained by the fermentation of Ledebouriella divaricata roots, Angelica dahurica roots, Angelica tenuissama roots, Magnolia liliflora buds, Asarum sieboldi roots, Paeonia × suffruticosa roots, Cnidium officinale roots, Angelica gigas roots, Auklandia lappa roots, Achyranthes japonica roots, Eucommia ulmoides bark, Angelica pubescens roots, Aconitum koreanum roots by the microorganism Acetobacter. | Skin conditioning |
Saccharomyces/(Achyranthes bidentata/Angelica gigas/Angelica pubescens/Angelica tenuissima/Asarum sieboldi/Cnidium officinale/Ledebouriella divaricata/Paeonia × suffruticosa) root/Eucommia ulmoides bark/Magnolia liliflora bud ferment filtrate | The filtrate of the product obtained by the fermentation of the roots of Achyranthes bidentata, Angelica gigas, Angelica pubescens, Angelica tenuissima, Asarum sieboldi, Cnidium officinale, Ledebouriella divaricata, Paeonia × suffruticosa, the bark of Eucommia ulmoides and the buds of Magnolia liliflora by the microorganism, Saccharomyces. | Skin conditioning |
Saccharomyces/Achyranthes bidentat root/Angelica gigas root/Angelica pubescens root/Angelica tenuissima root/Asarum sieboldi root/Cnidium officinale root/Eucommia ulmoides bark/Ledebouriella divaricata root/Magnolia liliflora bud/Paeonia × suffruticosa root ferment filtrate | The filtrate of the product obtained by the fermentation of the roots of Achyranthes bidentata, Angelica gigas, Angelica pubescens, Angelica tenuissima, Asarum sieboldi, Cnidium officinale, Ledebouriella divaricata, Paeonia × suffruticosa, the buds of Magnolia liliflora, and the bark of Eucommia ulmoides by the microorganism, Saccharomyces. | Skin conditioning |
Saccharomyces/Achyranthes bidentata root/Angelica gigas root/Angelica pubescens root/Angelica tenuissima root/Cnidium officinale root/Eucommia ulmoides bark/Ledebouriella divaricata root/Paeonia × suffruticosa root ferment filtrate | The filtrate of the product obtained by the fermentation of the roots of Achyranthes bidentata, Angelica gigas, Angelica pubescens, Angelica tenuissima, Cnidium officinale, Ledebouriella divaricata, Paeonia × suffruticosa, and the bark of Eucommia ulmoides by the microorganism, Saccharomyces. | Skin conditioning |
Saccharomyces/Camellia japonica flower/Castanea crenata shell/Diospyros kaki leaf/Paeonia × suffruticosa root/Rhus javanica/Sanguisorba officinalis root extract ferment filtrate | The filtrate of the product obtained by the fermentation of Camellia japonica flower extract, Castanea crenata shell extract, Diospyros kaki leaf extract, Paeonia × suffruticosa root extract, Rhus javanica extract and Sanguisorba officinalis root extract by the microorganism, Saccharomyces. | Skin conditioning |
Saccharomyces/Cyperus rotundus root/Magnolia obovata bark/Paeonia × suffruticosa root/Peach kernel ferment extract filtrate | The filtrate of the extract of the product obtained by the fermentation of the roots of Cyperus rotundus and Paeonia × suffruticosa, the bark of Magnolia obovata, and the kernel of Prunus persica (peach) by the microorganism, Saccharomyces. | Skin conditioning |
Saccharomyces/Ledebouriella divaricata root/Achyranthes bidentata root/Cnidium officinale root/Eucommia ulmoides bark/Angelica gigas root/Paeonia × suffruticosa root/Angelica tenuissim root/Asarum sieboldi root/Angelica pubescens root/Magnolia liliflora bud ferment filtrate | The filtrate of the product obtained by the fermentation of the roots of Ledebouriella divaricata, Achyranthes bidentata, Cnidium officinale, Angelica gigas, Paeonia × suffruticosa, Angelica tenuissima, Asarum sieboldi, Angelica pubescens, the bark of Eucommia ulmoides and the buds of Magnolia liliflora by the microorganism, Saccharomyces. | Skin conditioning |
7. Paeonia × suffruticosa—Toxicity
Moutan cortex is a safe raw material. There are no studies confirming its toxic effect. Benzoic acid present in the extracts is considered a harmful component, but in this species, it is present at low levels [119]. Attention should be paid to the ease of contamination of the raw material with heavy metals familiar to soil, irrigation waters, atmospheric dust, car and industrial exhaust fumes, as well as pesticides and fertilizers [120]. Moutan cortex can become contaminated with exogenous substances such as heavy metals, pesticide residues or excessive sulfur content from sulfur fumigation. Therefore, the determination of trace elements in Moutan cortex is essential to ensure the high quality of the raw material. Due to these reasons, the places where this species is grown are important [121,122,123].
8. Paeonia × suffruticosa—Pant Biotechnological Studies
Increasingly, the species P. × suffruticosa is becoming the subject of biotechnology research due to breeding problems such as severe browning, difficulty in differentiation and rooting, and low regeneration efficiency. Establishing an efficient regeneration system is considered to be an important goal among peony researchers.
The first research on P. × suffruticosa in vitro cultures was carried out in 1977 by Gildow and Mitchell [124]. Tissue cultures of P. × suffruticosa were established using explants of etiolated stems. Callus formation was induced on agar-solidified Schenk and Hildebrandt medium (SH) containing the plant growth regulators 2,4-dichlorophenoxyacetic acid (2,4-D)—0.2 mg/L and kinetin (KIN)—0.1 mg/L. Growth was tested on a range of liquid media: SH/2, SH, SH × 2 and SH—M, containing 1250, 2500, 5000 and 2500 mg/L potassium nitrate. The SH—M medium, additionally, contained 1650 mg/L ammonium nitrate. Growth measured as increased fresh weight was best on the SH/2, SH and SH—M media and was curtailed on the SH × 2 medium [124].
Zhu et al. recently described the callus induction, shoot organogenesis and plant regeneration using young P. × suffruticosa leaves as explants. Various media containing diverse plant growth regulators were assessed for their potency in propagation. After exposure of dark-adapted leaf discs to 30 μmol/m2s of light, inoculation in a Murashige and Skoog (MS) medium containing 0.2 mg/L 2,4-D, 0.2 mg/L 1-naphthaleneacetic acid (NAA) and 3.0 mg/L thidiazuron (TDZ) resulted in the highest callus induction rate, with values reaching up to 87.8%. The studies also documented MS with 0.2 mg/L NAA, 2.0 mg/L, 6-benzyladenine (6-BA) and 2.0 mg/L KIN to be the optimal medium for further callus proliferation under light. Inoculation on MS containing 2.0 mg/L 6-BA, 0.2 mg/L NAA and 0.3 mg/L TDZ medium allowed callus cultures to differentiate into adventitious shoots, whereas a similar rate of root formation was detected when 1/2 MS containing 0.1 mg/L NAA, 0.05 mg/L 3-indolebutyric acid (IBA) and 30 g/L sucrose medium was used [125].
Protocol for high-frequency callus induction and establishment of P. × suffruticosa was described by Chen et al. [126]. Cultures were started from flower petals as explants. MS medium supplemented with 2.0 mg/L 2,4-D, 1.5 mg/L 6-BA and 0.3 mg/L NAA was identified as the best medium for callus induction, achieving an induction rate of up to 98.52%. The highest P. × suffruticosa proliferation rate (234%) was achieved on MS medium supplemented with 0.2 mg/L NAA and 3.0 mg/L 6-BA. The highest callus differentiation rate (34.81%) was achieved on MS supplemented with 2.0 mg/L 6-BA and 0.5 mg/L zeatin (Zea). The highest rooting rate was 23.33% when using 1/2 MS supplemented with 0.1 mg/L NAA and 0.05 mg/L IBA [126].
9. Conclusions
Paeonia × suffruticosa root bark, under the name of Moutan cortex, was introduced for official medicinal use in European Union countries by Supplement 9.4 to the European Pharmacopoeia in 2018 [23]. This plant has long been known and used in TCM. According to the indications of TCM, the raw material has an antipyretic effect, regulates hormonal cycles in women, improves blood circulation, reduces swelling and accelerates the treatment of ulcers. Contemporary professional pharmacological research of this raw material has proven numerous valuable directions of its activity, e.g., antioxidant, cytoprotective, anti-cancer, immunomodulating, anti-inflammatory, cardioprotective, anti-atherosclerotic, anti-diabetic, hepatoprotective as well as antimicrobial properties. Moreover, the raw material shows neuroprotective activity and can be used in neurodegenerative diseases. Mainly two compounds present in the raw material have been indicated as responsible for this wide range of activity directions—paeonol (phenolic compound) and paeoniflorin (monoterpenoid glycoside), and, partly, also 1,2,3,4,6-penta-O-galloyl-β-D-glucopyranose. The roots, bark of the roots and other organs of P. × suffruticosa, hydrolates and seed oil, as well as callus cultures, can be used in accordance with the CosIng base in the European Union countries in the production of cosmetics.
There has been some biotechnological research aimed at developing effective in vitro micropropagation protocols of P. × suffruticosa.
Author Contributions
Data collection: M.K.-S. and A.S.; design of the study: H.E. and A.S.; analysis and interpretation of the data: M.K.-S., A.S. and H.E.; drafting the manuscript: M.K.-S. and A.S.; critical revision of the manuscript: H.E. and A.S. All authors have read and agreed to the published version of the manuscript.
Institutional Review Board Statement
Not applicable.
Informed Consent Statement
Not applicable.
Conflicts of Interest
The authors declare no conflict of interest.
Funding Statement
This research was funded by grand numbers: N42/DBS/000238 and N42/DBS/000273 supported by the Polish Ministry of Science and Higher Education.
Footnotes
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.
References
- 1.Hong D. In: Peonies of the World. Taxonomy and Phytogeography. Hong D., editor. Royal Botanic Gardens; Richmond, UK: 2010. [Google Scholar]
- 2.World Flora Online. [(accessed on 9 August 2022)]. Available online: http://www.worldfloraonline.org/
- 3.Zhao M., Wu S.P. A review of the ethnobotany, phytochemistry and pharmacology of tree peony (Sect. Moutan) S. Afr. J. Bot. 2019;124:556–563. doi: 10.1016/j.sajb.2019.05.018. [DOI] [Google Scholar]
- 4.Connor P. Paeon. In: Littleton C., editor. Gods, Goddesses, and Mythology. Marshall Cavendish; Tarrytown, NY, USA: 2005. p. 1069. [Google Scholar]
- 5.Sang T., Crawford D.J., Stuessy T.F. Documentation of reticulate evolution in peonies (Paeonia) using internal transcripted spacer sequences of nuclear ribosomal DNA: Implications for biogeography and concerted evolution. Proc. Natl. Acad. Sci. USA. 1995;92:6813–6817. doi: 10.1073/pnas.92.15.6813. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.He C., Peng B., Dan Y., Peng Y., Xiao P. Chemical taxonomy of tree peony species from China based on root cortex metabolic fingerprinting. Phytochemistry. 2014;107:69–79. doi: 10.1016/j.phytochem.2014.08.021. [DOI] [PubMed] [Google Scholar]
- 7.European Directorate for the Quality of Medicine & HealthCare . European Pharmacopoeia 10.0. Council of Europe; Strasbourg, France: 2021. [Google Scholar]
- 8.Lan B., Li J., Duan Q. An Encyclopedia of the Tree Peonies in China. China Science and Technology Press; Beijing, China: 2002. [Google Scholar]
- 9.HMPC European Medicines Agency. The Committee on Herbal Medicinal Products (HMPC) Public Statement on the Use of Herbal Medicinal Products Containing Estragole. [(accessed on 9 August 2022)]. Available online: https://www.ema.europa.eu/en/documents/other/second-draft-revision-1-public-statement-use-herbal-medicinal-products-containing-estragole_en.pdf.
- 10.Institute for Traditional Medicine [(accessed on 9 August 2022)]. Available online: http://www.itmonline.org/arts/peony.html.
- 11.European Directorate for the Quality of Medicines & HealthCare . European Pharmacopoeia 9.0. Council of Europe; Strasbourg, France: 2017. [Google Scholar]
- 12.Zhang X., Wang Y., Liang Q., Ma Z., Xiao C., Tan H., Gao Y. The correlation between chemical composition, as determined by UPLC-TOF-MS, and acute toxicity of Veratrum nigrum L. and Radix Paeoniae alba. Evid.-Based Complement. Altern. Med. 2014;2014:892797. doi: 10.1155/2014/892797. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Wang Y.L., Wang J.X., Hu X.X., Chen L., Qiu Z.K., Zhao N., Yu Z.D., Sun S.Z., Xu Y.Y., Guo Y., et al. Antidepressant-like effects of albiflorin extracted from Radix Paeoniae alba. J. Ethnopharmacol. 2016;179:9–15. doi: 10.1016/j.jep.2015.12.029. [DOI] [PubMed] [Google Scholar]
- 14.Tan Y.Q., Chen H.W., Li J., Wu Q.J. Efficacy, Chemical Constituents, and Pharmacological Actions of Radix Paeoniae rubra and Radix Paeoniae alba. Front. Pharmacol. 2020;11:1–11. doi: 10.3389/fphar.2020.01054. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Kataloh Sortiv Roslyn, Prydatnykh dlia Poshyrennia v Ukraini na 2018 rik (Vytiah) Ukraine: 2018. [Google Scholar]
- 16.Markovskyi Y. Dekoratyvnue mnoholetnyky. SPb. Myr Y Semia. 2002 [Google Scholar]
- 17.Pantsyreva H. Research of sortal resources of grape species of Paeonia L. in Ukraine. Sci. Bull. UNFU. 2018;28:74–78. doi: 10.15421/40280815. [DOI] [Google Scholar]
- 18.Qiu Z.K., He J.L., Liu X., Zeng J., Chen J.S., Nie H. Anti-PTSD-like effects of albiflorin extracted from Radix Paeoniae alba. J. Ethnopharmacol. 2017;198:324–330. doi: 10.1016/j.jep.2016.12.028. [DOI] [PubMed] [Google Scholar]
- 19.Tatsumi S., Mabuchi T., Abe T., Xu L., Minami T., Ito S. Analgesic effect of extracts of Chinese medicinal herbs Moutan cortex and Coicis semen on neuropathic pain in mice. Neurosci. Lett. 2004;370:130–134. doi: 10.1016/j.neulet.2004.08.043. [DOI] [PubMed] [Google Scholar]
- 20.Chun S.C., Jee S.Y., Lee S.G., Park S.J., Lee J.R., Kim S.C. Anti-inflammatory activity of the methanol extract of Moutan cortex in LPS-activated Raw264.7 cells. Evid.-Based Complement. Altern. Med. 2007;4:327–333. doi: 10.1093/ecam/nel093. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Koo Y.K., Kim J.M., Koo J.Y., Kang S.S., Bae K.H., Kim Y.S., Chung J.H., Yun-Choi H.S. Platelet anti-aggregatory and blood anti-coagulant effects of compounds isolated from Paeonia lactiflora and Paeonia suffruticosa. Pharmazie. 2010;65:624–628. [PubMed] [Google Scholar]
- 22.Zhou J., Zhou L., Hou D., Tang J., Sun J., Bondy S.C. Paeonol increases levels of cortical cytochrome oxidase and vascular actin and improves behavior in a rat model of Alzheimer’s disease. Brain Res. 2011;1388:141–147. doi: 10.1016/j.brainres.2011.02.064. [DOI] [PubMed] [Google Scholar]
- 23.European Directorate for the Quality of Medicines & HelthCare . European Pharmacopoeia 9.0. Council of Europe; Strasbourg, France: 2018. Supplement 9.4; p. 2474. [Google Scholar]
- 24.The Ministry of Health Labour and Welfare . The Japanese Pharmacopoeia. 18th ed. Pharmaceutical s and Medical Devices Agency; Tokyo, Japan: 2021. [Google Scholar]
- 25.Ministry of Food and Drug Safety . Korean Pharmacopoeia. 10th ed. Ministry of Food and Drug Safety; Cheongju-si, Republic of Korea: 2012. [Google Scholar]
- 26.Wagner H. Cortex Moutan—Mudanpi. In: Wagner H., Bauer R., Melchart D., Xiao P.-G., Staudinger A., editors. Chromatographic Fingerprint Analysis of Herbal Medicines Thin-Layer and High Performance Liquid Chromatography of Chinese Drugs. Springer International Publishing; Cham, Switzerland: 2015. pp. 91–103. [Google Scholar]
- 27.Yoshikawa M., Harada E., Minematsu T., Muraoka O., Yamahara J., Murakami N., Kitagawa I. Absolute stereostructures of paeonisothujone, a novel skeletal monoterpene ketone, and deoxypaeonisuffrone, and isopaeonisuffral, two new monoterpenes, from Moutan cortex. Chem. Pharm. Bull. 1994;42:736–738. doi: 10.1248/cpb.42.736. [DOI] [Google Scholar]
- 28.Yoshikawa M., Ohta T., Kawaguchi A., Matsuda H. Bioactive constituents of chinese natural medicines. V. Radical scavenging effect of Moutan cortex. (1): Absolute stereostructures of two monoterpenes, paeonisuffrone and paeonisuffral. Chem. Pharm. Bull. 2000;48:1327–1331. doi: 10.1248/cpb.48.1327. [DOI] [PubMed] [Google Scholar]
- 29.Ding L., Zhao F., Chen L., Jiang Z., Liu Y., Li Z., Qiu F., Yao X. New monoterpene glycosides from Paeonia suffruticosa Andrews and their inhibition on NO production in LPS-induced RAW 264.7 cells. Bioorgan. Med. Chem. Lett. 2012;22:7243–7247. doi: 10.1016/j.bmcl.2012.09.034. [DOI] [PubMed] [Google Scholar]
- 30.Xiao K., Song Q.H., Zhang S.W., Xuan L.J. A pyrrole derivative from Paeonia suffruticosa. Nat. Prod. Res. 2008;22:1614–1619. doi: 10.1080/14786410701855902. [DOI] [PubMed] [Google Scholar]
- 31.He C.N., Peng Y., Zhang Y.C., Xu L.J., Gu J., Xiao P.G. Phytochemical and biological studies of Paeoniaceae. Chem. Biodivers. 2010;91:52–80. doi: 10.1002/cbdv.200800341. [DOI] [PubMed] [Google Scholar]
- 32.Zhou Y., Zhang Y., Zong H., Lu X., Shen W., Zhuge B. Chemical constituents, antibacterial activity and mechanism of Paeonia suffruticosa Andr. buds extract against Staphylococcus aureus and Escherichia coli O157:H7. Nat. Prod. Res. 2021;35:1005–1009. doi: 10.1080/14786419.2019.1610961. [DOI] [PubMed] [Google Scholar]
- 33.Ding L., Zuo Q., Li D., Feng X., Gao X., Zhao F., Qiu F. A new phenone from the roots of Paeonia suffruticosa Andrews. Nat. Prod. Res. 2017;31:253–260. doi: 10.1080/14786419.2016.1230114. [DOI] [PubMed] [Google Scholar]
- 34.Zhao G.H., Shen Y.S., Ma J.B., Li F., Shi X.Q. Protection of polysaccharides-2b from mudan cortex of Paeonia suffruticosa Andr on diabetic cataract in rats. Zhongguo Zhong Yao Za Zhi. 2007;32:2036–2039. [PubMed] [Google Scholar]
- 35.Liu X., Xu Q., Mei L., Lei H., Wen Q., Miao J., Huang H., Chen D., Du S., Zhang S., et al. Paeonol attenuates acute lung injury by inhibiting HMGB1 in lipopolysaccharide-induced shock rats. Int. Immunopharmacol. 2018;61:169–177. doi: 10.1016/j.intimp.2018.05.032. [DOI] [PubMed] [Google Scholar]
- 36.Zhai T., Sun Y., Li H., Zhang J., Huo R., Li H., Shen B., Li N. Unique immunomodulatory effect of paeoniflorin on type I and II macrophages activities. J. Pharmacol. Sci. 2016;130:143–150. doi: 10.1016/j.jphs.2015.12.007. [DOI] [PubMed] [Google Scholar]
- 37.Wang Q., Xu X., Kang Z., Zhang Z., Li Y. Paeonol prevents IL-1β-induced inflammatory response and degradation of type II collagen in human primary chondrocytes. Artif. Cells Nanomed. Biotechnol. 2019;47:2139–2145. doi: 10.1080/21691401.2019.1613418. [DOI] [PubMed] [Google Scholar]
- 38.Li C.R., Zhou Z., Zhu D., Sun Y.N., Dai J.M., Wang S.Q. Protective effect of paeoniflorin on irradiation-induced cell damage involved in modulation of reactive oxygen species and the mitogen-activated protein kinases. Int. J. Biochem. Cell Biol. 2007;39:426–438. doi: 10.1016/j.biocel.2006.09.011. [DOI] [PubMed] [Google Scholar]
- 39.Yu J., Zhu X., Qi X., Che J., Cao B. Paeoniflorin protects human EA.hy926 endothelial cells against gamma-radiation induced oxidative injury by activating the NF-E2-related factor 2/heme oxygenase-1 pathway. Toxicol. Lett. 2013;218:224–234. doi: 10.1016/j.toxlet.2013.01.028. [DOI] [PubMed] [Google Scholar]
- 40.Wankun X., Wenzhen Y., Min Z., Weiyan Z., Huan C., Wei D., Lvzhen H., Xu Y., Xiaoxin L. Protective effect of paeoniflorin against oxidative stress in human retinal pigment epithelium in vitro. Mol. Vis. 2011;17:3512–3522. [PMC free article] [PubMed] [Google Scholar]
- 41.Weng Y.C., Jing P.M., Cheon K.K., Won C.J., Won H.J. 6’-O-galloylpaeoniflorin protects human keratinocytes against oxidative stress-induced cell damage. Biomol. Ther. 2013;21:349–357. doi: 10.4062/biomolther.2013.064. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Cai J., Chen S., Zhang W., Hu S., Lu J., Xing J., Dong Y. Paeonol reverses paclitaxel resistance in human breast cancer cells by regulating the expression of transgelin 2. Phytomedicine. 2014;21:984–991. doi: 10.1016/j.phymed.2014.02.012. [DOI] [PubMed] [Google Scholar]
- 43.Zhang L., Tao L., Shi T., Zhang F., Sheng X., Cao Y., Zheng S., Wang A., Qian W., Jiang L., et al. Paeonol inhibits B16F10 melanoma metastasis in vitro and in vivo via disrupting proinflammatory cytokines-mediated NF-κB and STAT3 pathways. IUBMB Life. 2015;67:778–788. doi: 10.1002/iub.1435. [DOI] [PubMed] [Google Scholar]
- 44.Horng C.T., Shieh P.C., Tan T.W., Yang W.H., Tang C.H. Paeonol suppresses chondrosarcoma metastasis through up-regulation of miR-141 by modulating PKCδ and c-Src signaling pathway. Int. J. Mol. Sci. 2014;15:11760–11772. doi: 10.3390/ijms150711760. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Rho S., Chung H.S., Kang M., Lee E., Cho C., Kim H., Park S., Kim H.Y., Hong M., Shin M., et al. Inhibition of production of reactive oxygen species and gene expression profile by treatment of ethanol extract of Moutan cortex radicis in oxidative stressed PC12 cells. Biol. Pharm. Bull. 2005;28:661–666. doi: 10.1248/bpb.28.661. [DOI] [PubMed] [Google Scholar]
- 46.Ou Y., Li Q., Wang J., Li K., Zhou S. Antitumor and apoptosis induction effects of paeonol on mice bearing EMT6 breast carcinoma. Biomol. Ther. 2014;22:341–346. doi: 10.4062/biomolther.2013.106. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Shu-Ping X., Guo-Ping S., Yu-Xian S., Wei W., Wan-Ren P., Hua W. Antiproliferation and apoptosis induction of paenol in HepG2 cells. World J. Gastroenterol. 2007;13:250–256. doi: 10.3748/wjg.v13.i2.250. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Sun G.-P., Wang H., Xu S.-P., Shen Y.-X., Wu Q., Chen Z.-D., Wei W. Anti-tumor effects of paeonol in a HepA-hepatoma bearing mouse model via induction of tumor cell apoptosis and stimulation of IL-2 and TNF-α production. Eur. J. Pharmacol. 2008;584:246–252. doi: 10.1016/j.ejphar.2008.02.016. [DOI] [PubMed] [Google Scholar]
- 49.Li N., Fan L.L., Sun G.P., Wan X.A., Wang Z.G., Wu Q., Wang H. Paeonol inhibits tumor growth in gastric cancer in vitro and in vivo. World J. Gastroenterol. 2010;16:4483–4490. doi: 10.3748/wjg.v16.i35.4483. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Wu Q., Chen G.L., Li Y.J., Chen Y., Lin F.Z. Paeoniflorin inhibits macrophage-mediated lung cancer metastasis. Chin. J. Nat. Med. 2015;13:925–932. doi: 10.1016/S1875-5364(15)30098-4. [DOI] [PubMed] [Google Scholar]
- 51.Li W., Qi Z., Wei Z., Liu S., Wang P., Chen Y., Zhao Y. Paeoniflorin inhibits proliferation and induces apoptosis of human glioma cells via microRNA-16 upregulation and matrix metalloproteinase-9 downregulation. Mol. Med. Rep. 2015;12:2735–2740. doi: 10.3892/mmr.2015.3718. [DOI] [PubMed] [Google Scholar]
- 52.Oh G.S., Pae H.O., Oh H., Hong S.G., Kim I.K., Chai K.Y., Yun Y.G., Kwon T.O., Chung H.T. In vitro anti-proliferative effect of 1,2,3,4,6-penta-O-galloyl-beta-D-glucose on human hepatocellular carcinoma cell line, SK-HEP-1 cells. Cancer Lett. 2001;174:17–24. doi: 10.1016/S0304-3835(01)00680-2. [DOI] [PubMed] [Google Scholar]
- 53.Lin M.-Y., Shen C.-H., Chiang S.-Y., Chen S.-Y., Lin Y.-S., Hsu C.-D. Cortex Moutan inhibits bladder cancer cell proliferation and expression of angiogenic factors. Pharmacol. Pharm. 2014;05:846–858. doi: 10.4236/pp.2014.58095. [DOI] [Google Scholar]
- 54.Liu Y.H., Weng Y.P., Tsai H.Y., Chen C.J., Lee D.Y., Hsieh C.L., Wu Y.C., Lin J.Y. Aqueous extracts of Paeonia suffruticosa modulates mitochondrial proteostasis by reactive oxygen species-induced endoplasmic reticulum stress in pancreatic cancer cells. Phytomedicine. 2018;46:184–192. doi: 10.1016/j.phymed.2018.03.037. [DOI] [PubMed] [Google Scholar]
- 55.Liu H., Zhang C. Paeonol induces antitumor effects in hepatocellular carcinoma cells through survivin via the cyclooxygenase-2/prostaglandin E2 signaling pathway. Transl. Cancer Res. 2020;9:7183–7195. doi: 10.21037/tcr-20-322A. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.Liu M.H., Lin A.H., Lee H.F., Ko H.K., Lee T.S., Kou Y.R. Paeonol attenuates cigarette smoke-induced lung inflammation by inhibiting ros-sensitive inflammatory signaling. Mediators Inflamm. 2014;2014:651890. doi: 10.1155/2014/651890. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Kim H.G., Park G., Piao Y., Kang M.S., Pak Y.K., Hong S.-P., Oh M.S. Effects of the root bark of Paeonia suffruticosa on mitochondria-mediated neuroprotection in an MPTP-induced model of Parkinson’s disease. Food Chem. Toxicol. 2014;65:293–300. doi: 10.1016/j.fct.2013.12.037. [DOI] [PubMed] [Google Scholar]
- 58.Wu J.-b., Song N.-n., Wei X.-b., Guan H.-s., Zhang X. Protective effects of paeonol on cultured rat hippocampal neurons against oxygen-glucose deprivation-induced injury. J. Neurol. Sci. 2008;264:50–55. doi: 10.1016/j.jns.2007.06.057. [DOI] [PubMed] [Google Scholar]
- 59.Himaya S.W.A., Ryu B., Qian Z.J., Kim S.K. Paeonol from Hippocampus kuda Bleeler suppressed the neuro-inflammatory responses in vitro via NF-κB and MAPK signaling pathways. Toxicol. In Vitro. 2012;26:878–887. doi: 10.1016/j.tiv.2012.04.022. [DOI] [PubMed] [Google Scholar]
- 60.Lin C., Lin H., Chen J., Tseng W., Ko P., Liu Y., Yeh W., Lu D. Effects of paeonol on anti-neuroinflammatory responses in microglial cells. Int. J. Mol. Sci. 2015;16:8844–8860. doi: 10.3390/ijms16048844. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61.Guo R., Wang G., Zhao A., Gu J., Sun X., Hu G. Paeoniflorin protects against ischemia-induced brain damages in rats via inhibiting MAPKs/NF-kB-mediated inflammatory responses. PLoS ONE. 2012;7:e49701. doi: 10.1371/journal.pone.0049701. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62.Choi B.-M., Kim H.-J., Oh G.-S., Pae H.-O., Oh H., Jeong S., Kwon T.-O., Kim Y.-M., Chung H.-T. 1,2,3,4,6-Penta-O-galloyl-beta-D-glucose protects rat neuronal cells (Neuro 2A) from hydrogen peroxide-mediated cell death via the induction of heme oxygenase-1. Neurosci. Lett. 2002;328:185–189. doi: 10.1016/S0304-3940(02)00513-X. [DOI] [PubMed] [Google Scholar]
- 63.Liu S., Li Y., Yi F., Liu Q., Chen N., He X., He C., Xiao P. Resveratrol Oligomers from Paeonia suffruticosa Protect Mice against Cognitive Dysfunction by Regulating Cholinergic, Antioxidant and Anti-Inflammatory Pathways. Volume 260. Elsevier B.V.; Amsterdam, The Netherlands: 2020. [DOI] [PubMed] [Google Scholar]
- 64.Li H., Xie Y.H., Yang Q., Wang S.W., Zhang B.L., Wang J.B., Cao W., Bi L.L., Sun J.Y., Miao S., et al. Cardioprotective effect of paeonol and danshensu combination on isoproterenol-induced myocardial injury in rats. PLoS ONE. 2012;7:e48872. doi: 10.1371/journal.pone.0048872. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 65.Yun C.S., Choi Y.G., Jeong M.Y., Lee J.H., Lim S. Moutan cortex radicis inhibits inflammatory changes of gene expression in lipopolysaccharide-stimulated gingival fibroblasts. J. Nat. Med. 2013;67:576–589. doi: 10.1007/s11418-012-0714-3. [DOI] [PubMed] [Google Scholar]
- 66.Li J.Z., Wu J.H., Yu S.Y., Shao Q.R., Dong X.M. Inhibitory effects of paeoniflorin on lysophosphatidylcholine-induced inflammatory factor production in human umbilical vein endothelial cells. Int. J. Mol. Med. 2013;31:493–497. doi: 10.3892/ijmm.2012.1211. [DOI] [PubMed] [Google Scholar]
- 67.Wu M., Gu Z. Screening of bioactive compounds from Moutan cortex and their anti-inflammatory activities in rat synoviocytes. Evid.-Based Complement. Altern. Med. 2009;6:57–63. doi: 10.1093/ecam/nem066. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 68.Oh G.S., Pae H.O., Choi B.M., Jeong S., Oh H., Rho Y.D., Kim D.H., Shin M.K., Chung H.T. Inhibitory effects of the root cortex of Paeonia suffruticosa on interleukin-8 and macrophage chemoattractant protein-1 secretions in U937 cells. J. Ethnopharmacol. 2003;84:85–89. doi: 10.1016/S0378-8741(02)00285-4. [DOI] [PubMed] [Google Scholar]
- 69.Chen N., Liu D., Soromou L.W., Sun J., Zhong W., Guo W., Huo M., Li H., Guan S., Chen Z., et al. Paeonol suppresses lipopolysaccharide- induced inflammatory cytokines in macrophage cells and protects mice from lethal endotoxin shock. Fundam. Clin. Pharmacol. 2013;28:268–276. doi: 10.1111/fcp.12019. [DOI] [PubMed] [Google Scholar]
- 70.Liu J., Wang S., Feng L., Ma D., Fu Q., Song Y., Jia X., Ma S. Hypoglycemic and antioxidant activities of paeonol and its beneficial effect on diabetic encephalopathy in streptozotocin-induced diabetic rats. J. Med. Food. 2013;16:577–586. doi: 10.1089/jmf.2012.2654. [DOI] [PubMed] [Google Scholar]
- 71.Fu J., Li Y., Wang L., Gao B., Zhang N., Ji Q. Paeoniflorin prevents diabetic nephropathy in rats. Comp. Med. 2009;59:557–566. [PMC free article] [PubMed] [Google Scholar]
- 72.Ha D.T., Tuan D.T., Thu N.B., Nhiem N.X., Ngoc T.M., Yim N., Bae K. Palbinone and triterpenes from Moutan cortex (Paeonia suffruticosa, Paeoniaceae) stimulate glucose uptake and glycogen synthesis via activation of AMPK in insulin-resistant human HepG2 Cells. Bioorganic Med. Chem. Lett. 2009;19:5556–5559. doi: 10.1016/j.bmcl.2009.08.048. [DOI] [PubMed] [Google Scholar]
- 73.Shon Y.-H., Nam K.-S. Protective effect of Moutan cortex extract on acetaminophen-induced hepatotoxicity in mice. J. Ethnopharmacol. 2004;90:415–419. doi: 10.1016/j.jep.2003.11.004. [DOI] [PubMed] [Google Scholar]
- 74.Hu S., Shen G., Zhao W., Wang F., Jiang X., Huang D. Paeonol, the main active principles of Paeonia moutan, ameliorates alcoholic steatohepatitis in mice. J. Ethnopharmacol. 2010;128:100–106. doi: 10.1016/j.jep.2009.12.034. [DOI] [PubMed] [Google Scholar]
- 75.Wu J., Xue X., Zhang B., Jiang W., Cao H., Wang R., Sun D., Guo R. The protective effects of paeonol against epirubicin-induced hepatotoxicity in 4T1-tumor bearing mice via inhibition of the PI3K/Akt/NF-kB pathway. Chem. Biol. Interact. 2016;244:1–8. doi: 10.1016/j.cbi.2015.11.025. [DOI] [PubMed] [Google Scholar]
- 76.Chen M., Cao L., Luo Y., Feng X., Sun L., Wen M., Peng S. Paeoniflorin protects against concanavalin A-induced hepatitis in mice. Int. Immunopharmacol. 2015;24:42–49. doi: 10.1016/j.intimp.2014.11.006. [DOI] [PubMed] [Google Scholar]
- 77.Zhao Y., Ma X., Wang J., Zhu Y., Li R., Wang J., He X., Shan L., Wang R., Wang L., et al. Paeoniflorin alleviates liver fibrosis by inhibiting HIF-1α through mTOR-dependent pathway. Fitoterapia. 2014;99:318–327. doi: 10.1016/j.fitote.2014.10.009. [DOI] [PubMed] [Google Scholar]
- 78.Hong D., Liping Z., Xiaolin Q., Xiaohui P., Mingyan W., Xuan T., Shanggong Y., Nianbai F. Moutan cortex extract exerts protective effects in a rat model of cardiac ischemia/reperfusion. Can. J. Physiol. Pharmacol. 2015;94:245–250. doi: 10.1139/cjpp-2015-0168. [DOI] [PubMed] [Google Scholar]
- 79.Chen C., Du P., Wang J. Paeoniflorin ameliorates acute myocardial infarction of rats by inhibiting inflammation and inducible nitric oxide synthase signaling pathways. Mol. Med. Rep. 2015;12:3937–3943. doi: 10.3892/mmr.2015.3870. [DOI] [PubMed] [Google Scholar]
- 80.Chen T., Guo Z.-P., Wang L., Qin S., Cao N., Li M.-M., Jia R.-Z., Wang T.-T. Paeoniflorin suppresses vascular damage and the expression of E-selectin and ICAM-1 in a mouse model of cutaneous Arthus reaction. Exp. Dermatol. 2013;22:453–457. doi: 10.1111/exd.12174. [DOI] [PubMed] [Google Scholar]
- 81.Ye S., Liu X., Mao B., Yang L., Liu N. Paeonol enhances thrombus recanalization by inducing vascular endothelial growth factor 165 via ERK1/2 MAPK signaling pathway. Mol. Med. Rep. 2016;13:4853–4858. doi: 10.3892/mmr.2016.5135. [DOI] [PubMed] [Google Scholar]
- 82.Ye S., Mao B., Yang L., Fu W., Hou J. Thrombosis recanalization by paeoniflorin through the upregulation of urokinase-type plasminogen activator via the MAPK signaling pathway. Mol. Med. Rep. 2016;13:4593–4598. doi: 10.3892/mmr.2016.5146. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 83.Wang Y., Dai M., Zhong J., Yin D. Paeonol inhibits oxidized low density lipoprotein-induced monocyte adhesion to vascular endothelial cells by inhibiting the mitogen activated protein kinase pathway. Biol. Pharm. Bull. 2012;35:767–772. doi: 10.1248/bpb.35.767. [DOI] [PubMed] [Google Scholar]
- 84.Ngo T., Kim K., Bian Y., Noh H., Lim K.M., Chung J.H., Bae O.N. Antithrombotic effects of paeoniflorin from Paeonia suffruticosa by selective inhibition on shear stress-induced platelet aggregation. Int. J. Mol. Sci. 2019;20:5040. doi: 10.3390/ijms20205040. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 85.Lau C.H., Chan C.M., Chan Y.W., Lau K.M., Lau T.W., Lam F.C., Law W.T., Che C.T., Leung P.C., Fung K.P., et al. Pharmacological investigations of the anti-diabetic effect of Cortex Moutan and its active component paeonol. Phytomedicine. 2007;14:778–784. doi: 10.1016/j.phymed.2007.01.007. [DOI] [PubMed] [Google Scholar]
- 86.Ding H.Y., Chou T.H., Lin R.J., Chan L.P., Wang G.H., Liang C.H. Antioxidant and antimelanogenic behaviors of Paeonia suffruticosa. Plant Foods Hum. Nutr. 2011;66:275–284. doi: 10.1007/s11130-011-0235-3. [DOI] [PubMed] [Google Scholar]
- 87.Lin D., Wang S.H., Song T.Y., Hsieh C.W., Tsai M.S. Safety and efficacy of tyrosinase inhibition of Paeonia suffruticosa Andrews extracts on human melanoma cells. J. Cosmet. Dermatol. 2019;18:1921–1929. doi: 10.1111/jocd.12902. [DOI] [PubMed] [Google Scholar]
- 88.Wang W., Li Q., Zhao Z., Liu Y., Wang Y., Xiong H., Mei Z. Paeonol ameliorates chronic itch and spinal astrocytic activation via CXCR3 in an experimental dry skin model in mice. Front. Pharmacol. 2022;12:1–15. doi: 10.1055/s-0041-1742095. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 89.Hong D.Y., Pan K.Y. Notes on taxonomy of Paeonia sect. Moutan DC. (Paeoniaceae) Acta Phytotaxon. Sin. 2005;43:169–177. doi: 10.1360/aps040065. [DOI] [Google Scholar]
- 90.Baoqing L. Chinese Peony Book I. Science and Technology of China Press. China Press; Beijing, China: 2002. [Google Scholar]
- 91.Wang Z., He C., Peng Y., Chen F., Xiao P. Origins, phytochemistry, pharmacology, analytical methods and safety of Cortex Moutan (Paeonia suffruticosa Andrew): A systematic review. Molecules. 2017;22:946. doi: 10.3390/molecules22060946. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 92.Fu P.K., Yang C.Y., Tsai T.H., Hsieh C.L. Moutan cortex radicis improves lipopolysaccharide-induced acute lung injury in rats through anti-inflammation. Phytomedicine. 2012;19:1206–1215. doi: 10.1016/j.phymed.2012.07.013. [DOI] [PubMed] [Google Scholar]
- 93.Junan F., Yan Z., Yongpeng X., Zongyin Q., Mengquan Z. Analysis on production history and production status of mudanpi in Chongqing Dianjiang. J. Chinese Med. Mater. 2006;29:41–43. [Google Scholar]
- 94.Zhou S.L., Zou X.H., Zhou Z.Q., Liu J., Xu C., Yu J., Wang Q., Zhang D.M., Wang X.Q., Ge S., et al. Multiple species of wild tree peonies gave rise to the “king of flowers”, Paeonia suffruticosa Andrews. Proceedings. Biol. Sci. 2014;281:20141687. doi: 10.1098/rspb.2014.1687. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 95.Ha D.T., Ngoc T.M., Lee I., Le Y.M., Kim J.S., Jung H., Lee S., Na M., Bae K. Inhibitors of aldose reductase and formation of advanced glycation end-products in Moutan cortex (Paeonia suffruticosa) J. Nat. Prod. 2009;72:1465–1470. doi: 10.1021/np9002004. [DOI] [PubMed] [Google Scholar]
- 96.Wu S.H., Wu D.G., Chen Y.W. Chemical constituents and bioactivities of plants from the genus Paeonia. Chem. Biodivers. 2010;7:90–104. doi: 10.1002/cbdv.200800148. [DOI] [PubMed] [Google Scholar]
- 97.Ding L., Jiang Z., Liu Y., Chen L., Zhao Q., Yao X., Zhao F., Qiu F. Monoterpenoid inhibitors of NO production from Paeonia suffruticosa. Fitoterapia. 2012;83:1598–1603. doi: 10.1016/j.fitote.2012.09.008. [DOI] [PubMed] [Google Scholar]
- 98.Song W.H., Cheng Z.H., Chen D.F. Anticomplement monoterpenoid glucosides from the root bark of Paeonia suffruticosa. J. Nat. Prod. 2014;77:42–48. doi: 10.1021/np400571x. [DOI] [PubMed] [Google Scholar]
- 99.Li G., Seo C.S., Lee K.S., Kim H.J., Chang H.W., Jung J.S., Song D.K., Son J.K. Protective constituents against sepsis in mice from the root cortex of Paeonia suffruticosa. Arch. Pharm. Res. 2004;27:1123–1126. doi: 10.1007/BF02975116. [DOI] [PubMed] [Google Scholar]
- 100.Lin H.C., Ding H.Y., Wu Y.C. Two novel compounds from Paeonia suffructicosa. J. Nat. Prod. 1998;61:343–346. doi: 10.1021/np9704258. [DOI] [PubMed] [Google Scholar]
- 101.Choi Y.H., Yoo H.J., Noh C., Lee J.M., Park J.W., Choi W.S., Choi J.H. Bioassay-guided isolation of novel compound from Paeonia suffruticosa Andrews roots as an IL-1β inhibitor. Arch. Pharm. Res. 2012;35:801–805. doi: 10.1007/s12272-012-0506-z. [DOI] [PubMed] [Google Scholar]
- 102.Lin H.C., Ding H.Y., Wu T.S., Wu P.L. Monoterpene glycosides from Paeonia suffruticosa. Phytochemistry. 1996;41:237–242. [Google Scholar]
- 103.Lai X., Wei J., Ding X. Paeoniflorin antagonizes TNF-α-Induced L929 fibroblastoma cells apoptosis by inhibiting NF-κBp65 activation. Dose-Response. 2018;16:1–7. doi: 10.1177/1559325818774977. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 104.Satoh K., Nagai F., Ushiyama K., Yasuda I., Seto T., Kano I. Inhibition of Na+, K+-ATPase by 1,2,3,4,6-Penta-O-galloyl-β-D-glucose, a major constituent of both Moutan cortex and Paeoniae radix. Biochem. Pharmacol. 1997;53:611–614. doi: 10.1016/S0006-2952(96)00828-3. [DOI] [PubMed] [Google Scholar]
- 105.Yin C., Zhang X., Li K., Bai Y., Yang P., Li C., Song X. Evaluation on the fresh eating quality of tree peony flowers. Food Biosci. 2022;47:101611. doi: 10.1016/j.fbio.2022.101611. [DOI] [Google Scholar]
- 106.Lei G., Song C., Wen X., Gao G., Qi Y. Chemical diversity and potential target network of woody peony flower essential oil from eleven representative cultivars (Paeonia × suffruticosa Andr.) Molecules. 2022;27:2829. doi: 10.3390/molecules27092829. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 107.He J., Dong Y., Liu X., Wan Y., Gu T., Zhou X., Liu M. Comparison of chemical compositions, antioxidant, and anti-photoaging activities of Paeonia suffruticosa flowers at different flowering stages. Antioxidants. 2019;8:345. doi: 10.3390/antiox8090345. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 108.Cao W., Wang Y., Shehzad Q., Liu Z., Zeng R. Effect of different solvents on the extraction of oil from peony seeds (Paeonia suffruticosa Andr.): Oil yield, fatty acids composition, minor components, and antioxidant capacity. J. Oleo Sci. 2022;71:333–342. doi: 10.5650/jos.ess21274. [DOI] [PubMed] [Google Scholar]
- 109.Zhang Q., Yuan Y., Cui J., Xiao T., Jiang D. Paeoniflorin inhibits proliferation and invasion of breast cancer cells through suppressing Notch-signaling pathway. Biomed. Pharmacother. 2016;78:197–203. doi: 10.1016/j.biopha.2016.01.019. [DOI] [PubMed] [Google Scholar]
- 110.Zhong S.-Z., Ge Q.-H., Rong Q., Li Q. Paeonol attenuates neurotoxicity and ameliorates cognitive impairment induced by d-galactose in ICR mice. J. Neurol. Sci. 2009;277:58–64. doi: 10.1016/j.jns.2008.10.008. [DOI] [PubMed] [Google Scholar]
- 111.Fujiwara H., Tabuchi M., Yamaguchi T., Iwasaki K., Furukawa K., Sekiguchi K., Ikarashi Y., Kudo Y., Higuchi M., Saido T.C., et al. A traditional medicinal herb Paeonia suffruticosa and its active constituent 1,2,3,4,6-penta-O-galloyl-β-D-glucopyranose have potent anti-aggregation effects on Alzheimer’s amyloid β proteins in vitro and in vivo. J. Neurochem. 2009;109:1648–1657. doi: 10.1111/j.1471-4159.2009.06069.x. [DOI] [PubMed] [Google Scholar]
- 112.Jiang S., Nakano Y., Yatsuzuka R., Ono R., Kamei C. Inhibitory effects of Moutan cortex on immediate allergic reactions. Biol. Pharm. Bull. 2007;30:1707–1710. doi: 10.1248/bpb.30.1707. [DOI] [PubMed] [Google Scholar]
- 113.Hong M.H., Kim J.H., Na S.H., Bae H., Shin Y.C., Kim S.H., Ko S.G. Inhibitory effects of Paeonia suffruticosa on allergic reactions by inhibiting the NF-kappaB/IkappaB-alpha signaling pathway and phosphorylation of ERK in an animal model and human mast cells. Biosci. Biotechnol. Biochem. 2010;74:1152–1156. doi: 10.1271/bbb.90676. [DOI] [PubMed] [Google Scholar]
- 114.Ma L., Jiao K., Luo L., Xiang J., Fan J., Zhang X., Yi J., Zhu W. Characterization and macrophage immunomodulatory activity of two polysaccharides from the flowers of Paeonia suffruticosa Andr. Int. J. Biol. Macromol. 2019;124:955–962. doi: 10.1016/j.ijbiomac.2018.12.035. [DOI] [PubMed] [Google Scholar]
- 115.Espiritu A.G., Doma B.T., Wang Y.F., Masim F.C. Efficacy of methanol extracts of Mentha haplocalyx Briq. and Paeonia suffruticosa Andr. for potential antibacterial activity. Sustain. Environ. Res. 2014;24:319–324. [Google Scholar]
- 116.Zhao Y., Wang B., Zhang S., Yang S., Wang H., Ren A., Yi E. Isolation of antifungal compound from Paeonia suffruticosa and its antifungal mechanism. Chin. J. Integr. Med. 2015;21:211–216. doi: 10.1007/s11655-014-1805-7. [DOI] [PubMed] [Google Scholar]
- 117.Sun Z.W., Du J., Hwang E., Yi T.-H. Paeonol extracted from Paeonia suffruticosa Andr. ameliorated UVB-induced skin photoaging via DLD/Nrf2/ARE and MAPK/ AP-1 pathway. Phyther. Res. 2018;32:1741–1749. doi: 10.1002/ptr.6100. [DOI] [PubMed] [Google Scholar]
- 118.European Commission CosIng—Cosmetic Database. [(accessed on 9 August 2022)]. Available online: https://ec.europa.eu/growth/tools-databases/cosing/index.cfm?fuseaction=search.simple.
- 119.Yue L.F., Huang X.W., Gao J.F., Zhanghong L., Wang D.M., Sun J.K., Zhang Z.G., Wang J.H., Liu J., Wang Y.M., et al. Determination of components in Radix Paeoniae rubra based on QAMS. Pak. J. Pharm. Sci. 2022;35:1037–1041. [PubMed] [Google Scholar]
- 120.Baye H., Hymete A. Lead and cadmium accumulation in medicinal plants collected from environmentally different sites. Bull. Environ. Contam. Toxicol. 2010;84:197–201. doi: 10.1007/s00128-009-9916-0. [DOI] [PubMed] [Google Scholar]
- 121.Liu Y., Xia Y., Guo P., Wang G., Shen Z., Xu Y., Chen Y. Copper and bacterial diversity in soil enhance paeonol accumulation in Cortex Moutan of Paeonia suffruticosa “Fengdan”. Hortic. Environ. Biotechnol. 2013;54:331–337. doi: 10.1007/s13580-013-0049-3. [DOI] [Google Scholar]
- 122.Li J., Wang Y., Yang H., Yu P., Tang Y. Five heavy metals accumulation and health risk in a traditional Chinese medicine Cortex Moutan collected from different sites in China. Hum. Ecol. Risk Assess. Int. J. 2018;24:2288–2298. doi: 10.1080/10807039.2018.1459181. [DOI] [Google Scholar]
- 123.Liu X.H. Analysis of heavy metal elements lead and cadmium in Cortex Moutan and its planting soil. Chinese J. Spectrosc. Lab. 2013;30:821–824. [Google Scholar]
- 124.Gildow F.E., Mitchell J.P. Initiation, growth and nuclear characteristics of tissue cultures of Paeonia suffruticosa. Physiol. Plant. 1977;39:295–298. doi: 10.1111/j.1399-3054.1977.tb01887.x. [DOI] [Google Scholar]
- 125.Zhu X., Li X., Ding W., Jin S., Wang Y. Callus induction and plant regeneration from leaves of peony. Hortic. Environ. Biotechnol. 2018;59:575–582. doi: 10.1007/s13580-018-0065-4. [DOI] [Google Scholar]
- 126.Chen X., Ye C., Yang H., Ji W., Xu Z., Ye S., Wang H., Jin S., Yu C., Zhu X. Callogenesis and plant regeneration in peony (Paeonia × suffruticosa) using flower petal explants. Horticulturae. 2022;8:1–10. doi: 10.3390/horticulturae8050357. [DOI] [Google Scholar]